candidate_genes,disease,celltype,y,user_question,full_query
"['COMMD6', 'PRKACG', 'TIGD2', 'LINC02813', 'GRIN2D']",type 1 diabetes mellitus,pancreatic epsilon cell,COMMD6,"Which gene among COMMD6, PRKACG, TIGD2, LINC02813, and GRIN2D shows the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Which gene among COMMD6, PRKACG, TIGD2, LINC02813, and GRIN2D shows the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify which of these targets overlap with the pancreatic epsilon cell–activated genes available in PINNACLE, forming a set of cell-type–specific targets. Compute the average embedding for this set and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RAB26', 'MAB21L2', 'NDUFA11', 'ALDOC', 'EGLN2']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA11,"Among the genes RAB26, MAB21L2, NDUFA11, ALDOC, and EGLN2, which exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Among the genes RAB26, MAB21L2, NDUFA11, ALDOC, and EGLN2, which exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Determine the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, identify which genes activated in pancreatic epsilon cells overlap with these targets, defining this intersection as the cell-type-specific targets for type 1 diabetes mellitus. Calculate the average embedding of these overlapping genes as a reference, then compute the cosine similarity between this reference and each individual target’s embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['INSYN2A', 'PMFBP1', 'MT-ND1', 'SCOC-AS1', 'MARVELD3']",type 1 diabetes mellitus,pancreatic epsilon cell,MT-ND1,"Among INSYN2A, PMFBP1, MT-ND1, SCOC-AS1, and MARVELD3, which gene exhibits the highest cell-type specificity in pancreatic epsilon cells and represents the most promising target for type 1 diabetes mellitus research?","Among INSYN2A, PMFBP1, MT-ND1, SCOC-AS1, and MARVELD3, which gene exhibits the highest cell-type specificity in pancreatic epsilon cells and represents the most promising target for type 1 diabetes mellitus research? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the pancreatic epsilon cell-activated genes in PINNACLE, defining a subset of cell-type–specific targets for the disease. Calculate the average embedding of this subset and then compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['POMGNT2', 'SUPT7L', 'PTPN18', 'GRID1', 'NDUFB1']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFB1,"Which gene among POMGNT2, SUPT7L, PTPN18, GRID1, and NDUFB1 exhibits the highest cell-type specific expression in pancreatic epsilon cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among POMGNT2, SUPT7L, PTPN18, GRID1, and NDUFB1 exhibits the highest cell-type specific expression in pancreatic epsilon cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Using PINNACLE, identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell‐type–specific embeddings. Next, determine the overlap between these targets and the pancreatic epsilon cell-activated genes in PINNACLE to define the cell-type–specific targets for T1DM. Compute the average embedding for the overlapping set, and then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NAIF1', 'PI4K2B', 'SLC35E3', 'NDUFA13', 'CAB39L']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA13,"Which gene among NAIF1, PI4K2B, SLC35E3, NDUFA13, and CAB39L exhibits the highest specificity in pancreatic epsilon cells, making it the best candidate for targeted studies in type 1 diabetes mellitus?","Which gene among NAIF1, PI4K2B, SLC35E3, NDUFA13, and CAB39L exhibits the highest specificity in pancreatic epsilon cells, making it the best candidate for targeted studies in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which among the pancreatic epsilon cell-activated genes in PINNACLE intersect with these targets. Calculate the average embedding of the overlapping set as a reference profile, then compute the cosine similarity between this reference and each individual candidate gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['DHRS12', 'SMIM28', 'NDUFB2', 'XAGE2', 'STK4']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFB2,"Among DHRS12, SMIM28, NDUFB2, XAGE2, and STK4, which gene shows the highest expression specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Among DHRS12, SMIM28, NDUFB2, XAGE2, and STK4, which gene shows the highest expression specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the pancreatic epsilon cell-activated genes in PINNACLE to define the set of cell-type–specific targets. Compute the average embedding for this set, then calculate the cosine similarity of each individual target’s embedding to this average. If one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['BLOC1S3', 'ZDHHC15', 'NHLH2', 'LINC02736', 'NDUFA3']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA3,"Among the genes BLOC1S3, ZDHHC15, NHLH2, LINC02736, and NDUFA3, which one shows the highest cell-type specificity in pancreatic epsilon cells as a potential target for type 1 diabetes mellitus?","Among the genes BLOC1S3, ZDHHC15, NHLH2, LINC02736, and NDUFA3, which one shows the highest cell-type specificity in pancreatic epsilon cells as a potential target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the pancreatic epsilon cell-activated genes in PINNACLE. Compute the average embedding for these overlapping genes to serve as a reference, and then evaluate the cosine similarity between each individual target’s embedding and this reference. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM258', 'SARAF', 'SRGAP3-AS4', 'FBXO41', 'UROC1']",type 1 diabetes mellitus,pancreatic epsilon cell,TMEM258,"Which gene among TMEM258, SARAF, SRGAP3-AS4, FBXO41, and UROC1 exhibits the highest expression specificity in pancreatic epsilon cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among TMEM258, SARAF, SRGAP3-AS4, FBXO41, and UROC1 exhibits the highest expression specificity in pancreatic epsilon cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine the subset of these targets that overlap with the genes activated in pancreatic epsilon cells. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between the reference and each individual target embedding. If one gene clearly shows a higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['NPDC1', 'OOSP2', 'NDUFA1', 'CLK1', 'C10orf67']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA1,"Among the genes NPDC1, OOSP2, NDUFA1, CLK1, and C10orf67, which one exhibits the highest specificity for pancreatic epsilon cells in the context of type 1 diabetes mellitus?","Among the genes NPDC1, OOSP2, NDUFA1, CLK1, and C10orf67, which one exhibits the highest specificity for pancreatic epsilon cells in the context of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, identify the genes activated in pancreatic epsilon cells from PINNACLE that overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LEKR1', 'ECH1', 'ESYT3', 'C15orf39', 'NDUFS7']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFS7,"Among the genes LEKR1, ECH1, ESYT3, C15orf39, and NDUFS7, which one exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the most promising target for type 1 diabetes mellitus?","Among the genes LEKR1, ECH1, ESYT3, C15orf39, and NDUFS7, which one exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the most promising target for type 1 diabetes mellitus? Using PINNACLE’s cell-type–specific embeddings, identify the verified therapeutic targets for type 1 diabetes mellitus. Next, determine which of these targets overlap with genes activated in pancreatic epsilon cells to define a set of cell-type–specific targets. Compute the average embedding for this subset and evaluate the cosine similarity between this reference and each individual target. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['IRX4-AS1', 'RABL6', 'C1orf43', 'INS', 'LINC01963']",type 1 diabetes mellitus,pancreatic epsilon cell,INS,"Among the genes IRX4-AS1, RABL6, C1orf43, INS, and LINC01963, which one exhibits the highest cell-type specificity in pancreatic epsilon cells for potential therapeutic targeting of type 1 diabetes mellitus?","Among the genes IRX4-AS1, RABL6, C1orf43, INS, and LINC01963, which one exhibits the highest cell-type specificity in pancreatic epsilon cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the activated genes in pancreatic epsilon cells as defined in PINNACLE. Compute the average embedding for the overlapping gene set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['EFCAB2', 'HSPH1', 'RPS26', 'TTLL3', 'ZC3H15']",type 1 diabetes mellitus,pancreatic epsilon cell,RPS26,"Among the genes EFCAB2, HSPH1, RPS26, TTLL3, and ZC3H15, which one exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Among the genes EFCAB2, HSPH1, RPS26, TTLL3, and ZC3H15, which one exhibits the highest cell-type specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic epsilon cell-activated genes in PINNACLE overlap with these targets, forming a subset of cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this subset, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFB2', 'SMARCAL1-AS1', 'USP51', 'SREK1', 'RBFA']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFB2,"Which gene among NDUFB2, SMARCAL1-AS1, USP51, SREK1, and RBFA exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among NDUFB2, SMARCAL1-AS1, USP51, SREK1, and RBFA exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which pancreatic epsilon cell–activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['SEMA3E', 'NDUFA3', 'C1RL', 'VRK1', 'SPEM1']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA3,"Which gene among SEMA3E, NDUFA3, C1RL, VRK1, and SPEM1 exhibits the highest specificity for pancreatic epsilon cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among SEMA3E, NDUFA3, C1RL, VRK1, and SPEM1 exhibits the highest specificity for pancreatic epsilon cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic epsilon cell-activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for the overlapping gene set and compute the cosine similarity between this average reference and each individual target embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['NDUFS7', 'ZRANB2-AS1', 'MFN2', 'TACR3', 'LINC01357']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFS7,"Among the genes NDUFS7, ZRANB2-AS1, MFN2, TACR3, and LINC01357, which one shows the highest expression specificity in pancreatic epsilon cells and could serve as a prime target for interventions in type 1 diabetes mellitus?","Among the genes NDUFS7, ZRANB2-AS1, MFN2, TACR3, and LINC01357, which one shows the highest expression specificity in pancreatic epsilon cells and could serve as a prime target for interventions in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of pancreatic epsilon cell-activated genes in PINNACLE, thereby defining the cell-type–specific targets for the disease. Compute the average embedding of these overlapping targets as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene displays markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NDUFA13', 'SENP5', 'VXN', 'LRRC28', 'TMC6']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA13,"Among the genes NDUFA13, SENP5, VXN, LRRC28, and TMC6, which exhibits the highest specificity for pancreatic epsilon cells as a potential target for type 1 diabetes mellitus?","Among the genes NDUFA13, SENP5, VXN, LRRC28, and TMC6, which exhibits the highest specificity for pancreatic epsilon cells as a potential target for type 1 diabetes mellitus? Identify all experimentally validated therapeutic targets for type 1 diabetes mellitus and obtain their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the set of pancreatic epsilon cell-activated genes available in PINNACLE; this overlapping group defines the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this intersecting set and then compute the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity score relative to the others, nominate it as the top candidate, providing a brief, evidence-based explanation for its biological relevance in type 1 diabetes mellitus."
"['CHMP4C', 'CYP27C1', 'NREP', 'RPS26', 'ANAPC2']",type 1 diabetes mellitus,pancreatic epsilon cell,RPS26,"Which gene among CHMP4C, CYP27C1, NREP, RPS26, and ANAPC2 exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the best candidate for targeted type 1 diabetes mellitus interventions?","Which gene among CHMP4C, CYP27C1, NREP, RPS26, and ANAPC2 exhibits the highest cell-type specificity in pancreatic epsilon cells, making it the best candidate for targeted type 1 diabetes mellitus interventions? Using the PINNACLE database, identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with genes activated in pancreatic epsilon cells to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TFIP11-DT', 'PLXDC1', 'ZNF274', 'NDUFA1', 'TMEM156']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA1,"Among the genes TFIP11-DT, PLXDC1, ZNF274, NDUFA1, and TMEM156, which one exhibits the highest cell-type-specific expression in pancreatic epsilon cells relevant to type 1 diabetes mellitus research?","Among the genes TFIP11-DT, PLXDC1, ZNF274, NDUFA1, and TMEM156, which one exhibits the highest cell-type-specific expression in pancreatic epsilon cells relevant to type 1 diabetes mellitus research? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic epsilon cells in PINNACLE. For the overlapping genes, calculate an average embedding as a reference and compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ATP1B1', 'ACAP3', 'LINC00665', 'FAHD2B', 'INS']",type 1 diabetes mellitus,pancreatic epsilon cell,INS,"Among the genes ATP1B1, ACAP3, LINC00665, FAHD2B, and INS, which one demonstrates the highest cell-type specificity in pancreatic epsilon cells, making it the most promising candidate for targeted type 1 diabetes mellitus interventions?","Among the genes ATP1B1, ACAP3, LINC00665, FAHD2B, and INS, which one demonstrates the highest cell-type specificity in pancreatic epsilon cells, making it the most promising candidate for targeted type 1 diabetes mellitus interventions? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell‐type–specific embeddings from PINNACLE. Determine which of these targets overlap with genes activated in pancreatic epsilon cells, and calculate the average embedding for this overlapping set as a reference. Next, compute the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate target and provide a brief, evidence-based rationale for its biological relevance."
"['COMMD6', 'FIBP', 'PRODH2', 'PPP1R3C', 'LINC02362']",type 1 diabetes mellitus,pancreatic epsilon cell,COMMD6,"Among the genes COMMD6, FIBP, PRODH2, PPP1R3C, and LINC02362, which one exhibits the highest specificity in pancreatic epsilon cells and is therefore the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes COMMD6, FIBP, PRODH2, PPP1R3C, and LINC02362, which one exhibits the highest specificity in pancreatic epsilon cells and is therefore the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the genes activated in pancreatic epsilon cells within PINNACLE to define cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding of the overlapping genes to serve as a reference, then compute the cosine similarity between this reference and each target embedding. Finally, if one gene demonstrates a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological importance."
"['CTRB2', 'AURKC', 'GSS', 'ITPKB', 'MTMR14']",type 1 diabetes mellitus,pancreatic d cell,CTRB2,"Which gene among CTRB2, AURKC, GSS, ITPKB, and MTMR14 shows the most pronounced expression specificity in pancreatic delta cells, thereby serving as the optimal candidate for targeted type 1 diabetes mellitus therapy?","Which gene among CTRB2, AURKC, GSS, ITPKB, and MTMR14 shows the most pronounced expression specificity in pancreatic delta cells, thereby serving as the optimal candidate for targeted type 1 diabetes mellitus therapy? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Determine which pancreatic d cell–activated genes in PINNACLE overlap with these targets. For the overlapping genes, compute the average embedding and then calculate the cosine similarity between this average vector and each individual gene embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND2', 'DDIAS', 'MEIKIN', 'LINC02818', 'OVGP1']",type 1 diabetes mellitus,pancreatic d cell,MT-ND2,"Which gene among MT-ND2, DDIAS, MEIKIN, LINC02818, and OVGP1 exhibits the highest specificity in pancreatic delta cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among MT-ND2, DDIAS, MEIKIN, LINC02818, and OVGP1 exhibits the highest specificity in pancreatic delta cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic d cell-activated genes overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of these overlapping targets and compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based justification for its biological relevance."
"['TBXAS1', 'EIF5A', 'PRRT4', 'IQCH-AS1', 'LINC02811']",type 1 diabetes mellitus,pancreatic d cell,EIF5A,"Which gene among TBXAS1, EIF5A, PRRT4, IQCH-AS1, and LINC02811 exhibits the highest cell-type specificity in pancreatic delta cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among TBXAS1, EIF5A, PRRT4, IQCH-AS1, and LINC02811 exhibits the highest cell-type specificity in pancreatic delta cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Using verified therapeutic targets for type 1 diabetes mellitus, obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlapping genes between these targets and the pancreatic d cell-activated genes annotated in PINNACLE to define cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between the reference and the embedding of each individual target gene. If one gene exhibits a substantially higher similarity compared with the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HAUS8', 'MED24', 'COLEC11', 'TP53RK-DT', 'RBM17']",type 1 diabetes mellitus,pancreatic d cell,RBM17,"Among HAUS8, MED24, COLEC11, TP53RK-DT, and RBM17, which gene exhibits the highest cell-type specificity in pancreatic delta cells relevant to type 1 diabetes mellitus?","Among HAUS8, MED24, COLEC11, TP53RK-DT, and RBM17, which gene exhibits the highest cell-type specificity in pancreatic delta cells relevant to type 1 diabetes mellitus? Using PINNACLE, identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type–specific embeddings. Next, determine which of these targets overlap with the pancreatic d cell–activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of this overlap set, then calculate the cosine similarity between the average and each individual target's embedding. If a single gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BSPRY', 'CDKN3', 'KCNQ4', 'LINC01948', 'M6PR']",type 1 diabetes mellitus,pancreatic d cell,M6PR,"Which gene among BSPRY, CDKN3, KCNQ4, LINC01948, and M6PR exhibits the highest cell-type specificity in pancreatic delta cells for potential therapeutic targeting in type 1 diabetes mellitus?","Which gene among BSPRY, CDKN3, KCNQ4, LINC01948, and M6PR exhibits the highest cell-type specificity in pancreatic delta cells for potential therapeutic targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic d cells as defined in PINNACLE. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this composite embedding and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['FAM78A', 'EFEMP1', 'HOXB8', 'PPIF', 'SLC28A2']",type 1 diabetes mellitus,pancreatic d cell,PPIF,"Among FAM78A, EFEMP1, HOXB8, PPIF, and SLC28A2, which gene exhibits the highest cell-type specificity in pancreatic δ cells and thereby represents the best candidate for therapeutic targeting in type 1 diabetes mellitus?","Among FAM78A, EFEMP1, HOXB8, PPIF, and SLC28A2, which gene exhibits the highest cell-type specificity in pancreatic δ cells and thereby represents the best candidate for therapeutic targeting in type 1 diabetes mellitus? Using the verified therapeutic targets for type 1 diabetes mellitus, retrieve their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the pancreatic d cell-activated genes in PINNACLE to define a set of cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate, providing a brief, evidence-based explanation of its biological relevance."
"['BNIP2', 'PANDAR', 'UMODL1', 'BFSP2', 'RSBN1']",type 1 diabetes mellitus,pancreatic d cell,RSBN1,"Among the genes BNIP2, PANDAR, UMODL1, BFSP2, and RSBN1, which one exhibits the highest specificity for pancreatic d cells and would therefore be the most appropriate candidate for targeting in type 1 diabetes mellitus?","Among the genes BNIP2, PANDAR, UMODL1, BFSP2, and RSBN1, which one exhibits the highest specificity for pancreatic d cells and would therefore be the most appropriate candidate for targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the intersection between these targets and the pancreatic d cell-activated genes in PINNACLE. Compute the average embedding of the overlapping targets as a reference profile and calculate the cosine similarity between this reference and each individual target embedding. Finally, nominate the gene that shows a significantly higher similarity than the others as the top candidate, providing a concise, evidence-based justification for its biological relevance."
"['ALDH2', 'PYDC1', 'CACYBP', 'RASGEF1C', 'MROH2B']",type 1 diabetes mellitus,pancreatic d cell,ALDH2,"Which gene—ALDH2, PYDC1, CACYBP, RASGEF1C, or MROH2B—demonstrates the highest specificity for pancreatic delta cells as a potential target in type 1 diabetes therapy?","Which gene—ALDH2, PYDC1, CACYBP, RASGEF1C, or MROH2B—demonstrates the highest specificity for pancreatic delta cells as a potential target in type 1 diabetes therapy? Using verified therapeutic targets for type 1 diabetes mellitus and their cell-type–specific embeddings from PINNACLE, identify which pancreatic d cell–activated genes overlap with these targets. Compute the average embedding of this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['JAK1', 'KCTD20', 'CTCFL', 'SNHG4', 'PIK3C2G']",type 1 diabetes mellitus,pancreatic d cell,JAK1,"Which gene among JAK1, KCTD20, CTCFL, SNHG4, and PIK3C2G exhibits the highest specificity for pancreatic δ-cells in the context of type 1 diabetes mellitus targeting?","Which gene among JAK1, KCTD20, CTCFL, SNHG4, and PIK3C2G exhibits the highest specificity for pancreatic δ-cells in the context of type 1 diabetes mellitus targeting? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Determine which of these targets overlap with genes activated in pancreatic d cells. For the overlapping set, compute the average embedding and evaluate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DEXI', 'ACAD11', 'GPR137', 'NWD2', 'OTUD6B-AS1']",type 1 diabetes mellitus,pancreatic d cell,DEXI,"Among the genes DEXI, ACAD11, GPR137, NWD2, and OTUD6B-AS1, which exhibits the greatest cell-type specificity in pancreatic delta cells, thereby presenting the most promising target for type 1 diabetes mellitus intervention?","Among the genes DEXI, ACAD11, GPR137, NWD2, and OTUD6B-AS1, which exhibits the greatest cell-type specificity in pancreatic delta cells, thereby presenting the most promising target for type 1 diabetes mellitus intervention? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the pancreatic d cell-activated genes in PINNACLE to define a set of cell-type–specific targets for type 1 diabetes. Compute the average embedding for this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target's embedding. Nominate as the top candidate the gene with a markedly higher similarity than the others, and provide a concise, evidence-based rationale for its biological relevance."
"['LINC01507', 'C1orf127', 'SCN11A', 'NDUFS7', 'RNF31']",type 1 diabetes mellitus,pancreatic d cell,NDUFS7,"Which gene among LINC01507, C1orf127, SCN11A, NDUFS7, and RNF31 demonstrates the highest cell-type specificity in pancreatic delta cells for targeted intervention in type 1 diabetes mellitus?","Which gene among LINC01507, C1orf127, SCN11A, NDUFS7, and RNF31 demonstrates the highest cell-type specificity in pancreatic delta cells for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic d cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlap set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['OR52E8', 'NDUFS3', 'TMEM132E', 'RBBP8NL', 'SMYD2']",type 1 diabetes mellitus,pancreatic d cell,NDUFS3,"Which gene among OR52E8, NDUFS3, TMEM132E, RBBP8NL, and SMYD2 shows the greatest specificity in pancreatic delta cells and emerges as the most promising candidate for targeted studies in type 1 diabetes mellitus?","Which gene among OR52E8, NDUFS3, TMEM132E, RBBP8NL, and SMYD2 shows the greatest specificity in pancreatic delta cells and emerges as the most promising candidate for targeted studies in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with pancreatic delta cell–activated genes in the PINNACLE dataset, defining this overlap as the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this set, then compute the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF764', 'CDC14A', 'WASF3-AS1', 'NDUFA6', 'RETSAT']",type 1 diabetes mellitus,pancreatic d cell,NDUFA6,"Which gene among ZNF764, CDC14A, WASF3-AS1, NDUFA6, and RETSAT exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus?","Which gene among ZNF764, CDC14A, WASF3-AS1, NDUFA6, and RETSAT exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the pancreatic d cell–activated genes defined in PINNACLE. Using the overlapping set, calculate an average embedding as a reference, then compute the cosine similarity between this reference and each gene’s individual embedding. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PCDHGC4', 'NDUFAF8', 'GORASP2', 'RGS13', 'WFDC2']",type 1 diabetes mellitus,pancreatic d cell,GORASP2,"Among the following genes—PCDHGC4, NDUFAF8, GORASP2, RGS13, and WFDC2—which shows the highest cell-type specificity in pancreatic delta cells for targeted interventions in type 1 diabetes mellitus?","Among the following genes—PCDHGC4, NDUFAF8, GORASP2, RGS13, and WFDC2—which shows the highest cell-type specificity in pancreatic delta cells for targeted interventions in type 1 diabetes mellitus? Identify the experimentally validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic d cells, defining the intersection as the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this set as a reference, then calculate the cosine similarity between the reference and each individual target embedding. If one gene shows a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GDPD3', 'DCST2', 'CCNG1', 'H2BC4', 'ZNF503-AS1']",type 1 diabetes mellitus,pancreatic d cell,H2BC4,"Among the genes GDPD3, DCST2, CCNG1, H2BC4, and ZNF503-AS1, which one exhibits the highest specificity for pancreatic delta cells in the context of type 1 diabetes mellitus?","Among the genes GDPD3, DCST2, CCNG1, H2BC4, and ZNF503-AS1, which one exhibits the highest specificity for pancreatic delta cells in the context of type 1 diabetes mellitus? Retrieve the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic d cell–activated genes in PINNACLE to define the set of cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFA12', 'KIAA1671-AS1', 'S100Z', 'IFI27', 'EDRF1-AS1']",type 1 diabetes mellitus,pancreatic d cell,NDUFA12,"Which gene—NDUFA12, KIAA1671-AS1, S100Z, IFI27, or EDRF1-AS1—exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus?","Which gene—NDUFA12, KIAA1671-AS1, S100Z, IFI27, or EDRF1-AS1—exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of pancreatic d cell-activated genes in PINNACLE. Using the overlapping genes as the cell-type–specific targets for type 1 diabetes, compute an average embedding to serve as a reference vector, and then calculate the cosine similarity between this reference and each individual target. If one gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological significance."
"['POGZ', 'LINC01535', 'LINC01678', 'TDRD5', 'NDUFA10']",type 1 diabetes mellitus,pancreatic d cell,NDUFA10,"Which gene among POGZ, LINC01535, LINC01678, TDRD5, and NDUFA10 exhibits the highest cell-type specificity in pancreatic delta cells for potential targeting in type 1 diabetes mellitus?","Which gene among POGZ, LINC01535, LINC01678, TDRD5, and NDUFA10 exhibits the highest cell-type specificity in pancreatic delta cells for potential targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Then, determine which pancreatic d cell-activated genes in PINNACLE overlap with these targets to establish a set of cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual gene’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['ALKAL2', 'ATXN7L3B', 'TPM4', 'PLEKHN1', 'CPSF7']",type 1 diabetes mellitus,pancreatic d cell,ATXN7L3B,"Among the genes ALKAL2, ATXN7L3B, TPM4, PLEKHN1, and CPSF7, which shows the highest cell-type-specific expression in pancreatic d cells, making it the most suitable candidate for targeting type 1 diabetes mellitus?","Among the genes ALKAL2, ATXN7L3B, TPM4, PLEKHN1, and CPSF7, which shows the highest cell-type-specific expression in pancreatic d cells, making it the most suitable candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the genes activated in pancreatic d cells to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference embedding and each individual target gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C14orf93', 'CNTN1', 'WASF3', 'PTPN20', 'LINC02516']",type 1 diabetes mellitus,pancreatic d cell,CNTN1,"Which gene—C14orf93, CNTN1, WASF3, PTPN20, or LINC02516—exhibits the highest cell-type specificity in pancreatic delta cells with implications for targeting type 1 diabetes mellitus?","Which gene—C14orf93, CNTN1, WASF3, PTPN20, or LINC02516—exhibits the highest cell-type specificity in pancreatic delta cells with implications for targeting type 1 diabetes mellitus? Using the PINNACLE dataset, first identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings. Next, determine which pancreatic d cell-activated genes overlap with these targets to define a subset of cell-type-specific therapeutic targets. Calculate the average embedding for these overlapping genes, and then determine the cosine similarity between this reference vector and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['P2RX1', 'NMRK1', 'FBXO24', 'NDUFA9', 'SFXN4']",type 1 diabetes mellitus,pancreatic d cell,NDUFA9,"Among P2RX1, NMRK1, FBXO24, NDUFA9, and SFXN4, which gene exhibits the most cell-type–specific expression in pancreatic delta cells and represents the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among P2RX1, NMRK1, FBXO24, NDUFA9, and SFXN4, which gene exhibits the most cell-type–specific expression in pancreatic delta cells and represents the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets are among the pancreatic d cell-activated genes represented in PINNACLE. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['GALK1', 'HCG14', 'LINC02097', 'GRB10', 'LINC02596']",type 1 diabetes mellitus,pancreatic ductal cell,GRB10,"Which gene among GALK1, HCG14, LINC02097, GRB10, and LINC02596 exhibits the highest expression specificity in pancreatic ductal cells, thereby representing the most promising target for type 1 diabetes mellitus?","Which gene among GALK1, HCG14, LINC02097, GRB10, and LINC02596 exhibits the highest expression specificity in pancreatic ductal cells, thereby representing the most promising target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the subset of these targets that are activated in pancreatic ductal cells as represented in PINNACLE. Compute the average embedding for the overlapping genes and calculate the cosine similarity between this average and the embedding of each individual target gene. Finally, select the gene with the highest similarity as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TMEM187', 'UGT2B17', 'ANXA5', 'PIK3R6', 'SERPINB3']",type 1 diabetes mellitus,pancreatic ductal cell,ANXA5,"Among the genes TMEM187, UGT2B17, ANXA5, PIK3R6, and SERPINB3, which one exhibits the highest specificity for pancreatic ductal cells in the context of type 1 diabetes mellitus, making it the most promising candidate for targeted intervention?","Among the genes TMEM187, UGT2B17, ANXA5, PIK3R6, and SERPINB3, which one exhibits the highest specificity for pancreatic ductal cells in the context of type 1 diabetes mellitus, making it the most promising candidate for targeted intervention? Identify the verified therapeutic targets for type 1 diabetes mellitus that have corresponding cell-type–specific embeddings in the PINNACLE database. Next, from the subset of pancreatic ductal cell-activated genes in PINNACLE, determine which ones overlap with these targets. For this overlapping set, compute the average embedding to serve as a reference and then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in type 1 diabetes mellitus."
"['KLHDC9', 'SRARP', 'ZBTB22', 'AGO4', 'SCN11A']",type 1 diabetes mellitus,pancreatic ductal cell,ZBTB22,"Among the genes KLHDC9, SRARP, ZBTB22, AGO4, and SCN11A, which one shows the highest cell-type specificity in pancreatic ductal cells in the context of type 1 diabetes mellitus?","Among the genes KLHDC9, SRARP, ZBTB22, AGO4, and SCN11A, which one shows the highest cell-type specificity in pancreatic ductal cells in the context of type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, compare these targets with the genes activated in pancreatic ductal cells from PINNACLE to identify overlapping genes. Calculate the average embedding of the overlapping set and determine the cosine similarity between this average profile and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FBXL5', 'NDUFB1', 'ZNF540', 'WWC2-AS2', 'LSM11']",type 1 diabetes mellitus,pancreatic ductal cell,NDUFB1,"Among the genes FBXL5, NDUFB1, ZNF540, WWC2-AS2, and LSM11, which one exhibits the most specific expression in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus?","Among the genes FBXL5, NDUFB1, ZNF540, WWC2-AS2, and LSM11, which one exhibits the most specific expression in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus from PINNACLE and obtain their cell-type–specific embeddings. Among these, determine which genes activated in pancreatic ductal cells overlap with the therapeutic targets. Compute the average embedding for the overlapping set, then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['TGFB1I1', 'CASP14', 'NPIPA1', 'HECTD4', 'TECR']",type 1 diabetes mellitus,pancreatic ductal cell,HECTD4,"Among the genes TGFB1I1, CASP14, NPIPA1, HECTD4, and TECR, which one exhibits the highest cell-type specificity for pancreatic ductal cells in the context of targeting type 1 diabetes mellitus?","Among the genes TGFB1I1, CASP14, NPIPA1, HECTD4, and TECR, which one exhibits the highest cell-type specificity for pancreatic ductal cells in the context of targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the pancreatic ductal cell-activated genes listed in PINNACLE. Compute the average embedding for this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FAM13C', 'NDUFA11', 'MEIS1-AS3', 'FANCD2OS', 'SLC5A8']",type 1 diabetes mellitus,pancreatic ductal cell,NDUFA11,"Among the genes FAM13C, NDUFA11, MEIS1-AS3, FANCD2OS, and SLC5A8, which one exhibits the greatest cell-type specificity in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus?","Among the genes FAM13C, NDUFA11, MEIS1-AS3, FANCD2OS, and SLC5A8, which one exhibits the greatest cell-type specificity in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus? Identify therapeutic targets for type 1 diabetes mellitus with established validation and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic ductal cells as identified in PINNACLE. Compute the average embedding of the overlapping targets to serve as a reference, and calculate the cosine similarity between this reference and each individual target's embedding. Finally, if one gene shows a significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based justification of its biological relevance."
"['CTSH', 'TPP1', 'BORCS5', 'USP4', 'USP9X']",type 1 diabetes mellitus,pancreatic ductal cell,CTSH,"Which gene among CTSH, TPP1, BORCS5, USP4, and USP9X exhibits the highest cell-type specificity in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus?","Which gene among CTSH, TPP1, BORCS5, USP4, and USP9X exhibits the highest cell-type specificity in pancreatic ductal cells for potential targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the genes activated in pancreatic ductal cells in PINNACLE, and consider that overlapping set as the putative cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for these targets and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PDGFD', 'NRXN3', 'HAPLN2', 'ATOH8', 'CD163L1']",type 1 diabetes mellitus,pancreatic ductal cell,PDGFD,"Which gene among PDGFD, NRXN3, HAPLN2, ATOH8, and CD163L1 exhibits the highest cell-type specificity in pancreatic ductal cells, thereby representing the most promising therapeutic target for type 1 diabetes mellitus?","Which gene among PDGFD, NRXN3, HAPLN2, ATOH8, and CD163L1 exhibits the highest cell-type specificity in pancreatic ductal cells, thereby representing the most promising therapeutic target for type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic ductal cells as identified in PINNACLE. For the overlapping set, compute the average embedding and calculate the cosine similarity between this reference embedding and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DNAJB13', 'CD46', 'ZNF264', 'PTRHD1', 'PCDHGA1']",type 1 diabetes mellitus,pancreatic ductal cell,PTRHD1,"Which gene among DNAJB13, CD46, ZNF264, PTRHD1, and PCDHGA1 demonstrates the greatest specificity for pancreatic ductal cells and thus represents the best candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among DNAJB13, CD46, ZNF264, PTRHD1, and PCDHGA1 demonstrates the greatest specificity for pancreatic ductal cells and thus represents the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the pancreatic ductal cell-activated genes in PINNACLE. Compute the average embedding of this overlapping gene set as a reference, then calculate the cosine similarity between this reference and each individual gene's embedding. If one gene shows a markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['P2RY6', 'BRD2', 'MUCL3', 'THOC1-DT', 'CLIP2']",type 1 diabetes mellitus,pancreatic ductal cell,BRD2,"Among the genes P2RY6, BRD2, MUCL3, THOC1-DT, and CLIP2, which exhibits the highest cell-type specificity in pancreatic ductal cells as the most promising single candidate for targeting in type 1 diabetes mellitus?","Among the genes P2RY6, BRD2, MUCL3, THOC1-DT, and CLIP2, which exhibits the highest cell-type specificity in pancreatic ductal cells as the most promising single candidate for targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which pancreatic ductal cell-activated genes from PINNACLE overlap with these targets. For this overlapping set, compute the average embedding and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a distinctly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TENT5C', 'DNM3', 'FMNL3', 'PCAT14', 'AGO2']",type 1 diabetes mellitus,pancreatic ductal cell,AGO2,"Which of the following genes—TENT5C, DNM3, FMNL3, PCAT14, or AGO2—exhibits the highest cell-type specificity in pancreatic ductal cells relevant to type 1 diabetes mellitus?","Which of the following genes—TENT5C, DNM3, FMNL3, PCAT14, or AGO2—exhibits the highest cell-type specificity in pancreatic ductal cells relevant to type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic ductal cells, thereby defining a set of cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['USP54', 'FAM41C', 'NDRG2', 'PHYHD1', 'ZMIZ1']",type 1 diabetes mellitus,pancreatic ductal cell,ZMIZ1,"Which gene among USP54, FAM41C, NDRG2, PHYHD1, and ZMIZ1 exhibits the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus?","Which gene among USP54, FAM41C, NDRG2, PHYHD1, and ZMIZ1 exhibits the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, identify which pancreatic ductal cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set and then calculate the cosine similarity between the average embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CARMIL1', 'FAM83F', 'TMEM210', 'ZNF559-ZNF177', 'FAM120C']",type 1 diabetes mellitus,pancreatic ductal cell,CARMIL1,"Among the genes CARMIL1, FAM83F, TMEM210, ZNF559-ZNF177, and FAM120C, which exhibits the highest cell-type specificity in pancreatic ductal cells and is therefore the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes CARMIL1, FAM83F, TMEM210, ZNF559-ZNF177, and FAM120C, which exhibits the highest cell-type specificity in pancreatic ductal cells and is therefore the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell type–specific embeddings from PINNACLE. Next, determine which of these targets are also activated in pancreatic ductal cells. Compute the average embedding of this overlapping gene set and calculate the cosine similarity between the average and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFIH1', 'EMSLR', 'PPP4R1', 'MGC4859', 'IKBKB-DT']",type 1 diabetes mellitus,pancreatic ductal cell,IFIH1,"Among IFIH1, EMSLR, PPP4R1, MGC4859, and IKBKB-DT, which gene exhibits the highest specificity in pancreatic ductal cells, indicating its potential as a target for type 1 diabetes mellitus interventions?","Among IFIH1, EMSLR, PPP4R1, MGC4859, and IKBKB-DT, which gene exhibits the highest specificity in pancreatic ductal cells, indicating its potential as a target for type 1 diabetes mellitus interventions? Identify validated therapeutic targets for type 1 diabetes and extract their cell-type–specific embeddings from the PINNACLE dataset. Then, determine the intersection between these targets and the genes activated in pancreatic ductal cells within PINNACLE. Calculate the average embedding of this overlapping set as a reference and compute the cosine similarity between each individual target’s embedding and this reference. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DPF1', 'CLDN7', 'LAMTOR3', 'PIGL', 'FAAP100']",type 1 diabetes mellitus,pancreatic ductal cell,CLDN7,"Which gene among DPF1, CLDN7, LAMTOR3, PIGL, and FAAP100 exhibits the highest cell-type specificity in pancreatic ductal cells as a potential target for type 1 diabetes mellitus therapy?","Which gene among DPF1, CLDN7, LAMTOR3, PIGL, and FAAP100 exhibits the highest cell-type specificity in pancreatic ductal cells as a potential target for type 1 diabetes mellitus therapy? Retrieve the cell type–specific embeddings from PINNACLE for all verified therapeutic targets related to type 1 diabetes mellitus. Next, identify the subset of these targets that overlap with genes activated in pancreatic ductal cells. For this overlapping set, calculate the average embedding to serve as a reference, then determine the cosine similarity between this reference and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['LINC01435', 'DHRS3', 'H4C3', 'ZNF534', 'MAGI1']",type 1 diabetes mellitus,pancreatic ductal cell,H4C3,"Which gene among LINC01435, DHRS3, H4C3, ZNF534, and MAGI1 exhibits the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus?","Which gene among LINC01435, DHRS3, H4C3, ZNF534, and MAGI1 exhibits the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic ductal cells in PINNACLE, thereby delineating cell-type–specific therapeutic candidates. Calculate the average embedding of the overlapping set, then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TEKT5', 'UCHL3', 'PRSS57', 'CDH18-AS1', 'TSN']",type 1 diabetes mellitus,pancreatic ductal cell,UCHL3,"Which gene among TEKT5, UCHL3, PRSS57, CDH18-AS1, and TSN exhibits the most specific expression in pancreatic ductal cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among TEKT5, UCHL3, PRSS57, CDH18-AS1, and TSN exhibits the most specific expression in pancreatic ductal cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus? Identify and retrieve the verified therapeutic targets for type 1 diabetes mellitus along with their corresponding cell-type–specific embeddings from PINNACLE. Then, determine which pancreatic ductal cell-activated genes in PINNACLE overlap with these targets to define cell-type–specific targets for the disease. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual target’s embedding. If one gene exhibits substantially higher similarity than others, nominate it as the top candidate, providing a concise, evidence-supported rationale for its biological relevance."
"['SYNPR', 'SLC9A3R1-AS1', 'UTP11', 'HLA-DMB', 'UACA']",type 1 diabetes mellitus,pancreatic ductal cell,HLA-DMB,"Among the candidate genes (SYNPR, SLC9A3R1-AS1, UTP11, HLA-DMB, and UACA), which one is most specifically expressed in pancreatic ductal cells, making it a compelling target for type 1 diabetes mellitus?","Among the candidate genes (SYNPR, SLC9A3R1-AS1, UTP11, HLA-DMB, and UACA), which one is most specifically expressed in pancreatic ductal cells, making it a compelling target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, intersect these targets with the genes activated in pancreatic ductal cells within the PINNACLE dataset to define the subset of cell-type–specific targets for type 1 diabetes. Compute the average embedding for this subset and then calculate the cosine similarity between this reference embedding and the embedding of each individual target. Finally, if one target gene exhibits a distinctly higher similarity compared to the others, nominate this gene as the primary candidate and provide a concise, evidence-based justification for its biological relevance."
"['ZNF682', 'ANAPC13', 'IRF2', 'ANXA6', 'KRTAP1-5']",type 1 diabetes mellitus,pancreatic ductal cell,IRF2,"Among the genes ZNF682, ANAPC13, IRF2, ANXA6, and KRTAP1-5, which shows the highest cell-type specificity in pancreatic ductal cells relevant to type 1 diabetes mellitus research?","Among the genes ZNF682, ANAPC13, IRF2, ANXA6, and KRTAP1-5, which shows the highest cell-type specificity in pancreatic ductal cells relevant to type 1 diabetes mellitus research? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the pancreatic ductal cell–activated genes in PINNACLE overlap with these targets. From this overlapping set, calculate the average embedding to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['VPS45', 'DDX27', 'ATXN2', 'KCNJ13', 'SREBF2-AS1']",type 1 diabetes mellitus,pancreatic ductal cell,ATXN2,"Among the genes VPS45, DDX27, ATXN2, KCNJ13, and SREBF2-AS1, which exhibits the highest cell-type specificity in pancreatic ductal cells as a potential target for type 1 diabetes mellitus?","Among the genes VPS45, DDX27, ATXN2, KCNJ13, and SREBF2-AS1, which exhibits the highest cell-type specificity in pancreatic ductal cells as a potential target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of pancreatic ductal cell–activated genes from PINNACLE. Calculate the average embedding of the overlapping gene set, then compute the cosine similarity between this average and each individual target's embedding. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLITRK6', 'AARSD1', 'B4GALT4', 'EPS15L1', 'SLC1A5']",type 1 diabetes mellitus,endothelial cell,SLC1A5,"Which gene among SLITRK6, AARSD1, B4GALT4, EPS15L1, and SLC1A5 demonstrates the highest endothelial cell-specific expression for potential targeting in type 1 diabetes mellitus?","Which gene among SLITRK6, AARSD1, B4GALT4, EPS15L1, and SLC1A5 demonstrates the highest endothelial cell-specific expression for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of these overlapping genes as a reference and compute the cosine similarity between this reference and each individual target. Finally, if one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM158', 'C4orf46', 'PRDX5', 'PCOLCE', 'GAS5-AS1']",type 1 diabetes mellitus,endothelial cell,PRDX5,"Among TMEM158, C4orf46, PRDX5, PCOLCE, and GAS5-AS1, which gene exhibits the highest endothelial cell specificity relevant to type 1 diabetes mellitus targeting?","Among TMEM158, C4orf46, PRDX5, PCOLCE, and GAS5-AS1, which gene exhibits the highest endothelial cell specificity relevant to type 1 diabetes mellitus targeting? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific candidate targets. Compute the average embedding of this set as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND3', 'MTPN', 'SLC7A8', 'LINC01754', 'LINC02585']",type 1 diabetes mellitus,endothelial cell,MT-ND3,"Among the genes MT-ND3, MTPN, SLC7A8, LINC01754, and LINC02585, which exhibits the highest endothelial cell-specific expression for potential targeted intervention in type 1 diabetes mellitus?","Among the genes MT-ND3, MTPN, SLC7A8, LINC01754, and LINC02585, which exhibits the highest endothelial cell-specific expression for potential targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus that have cell-type-specific embeddings in PINNACLE. From these, determine which genes overlap with the endothelial cell-activated set. Compute the average embedding of this overlapping group and assess the cosine similarity between this average and the individual embeddings of each target gene. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM14C', 'SMCR5', 'ATP2B2', 'NDUFB5', 'MNX1']",type 1 diabetes mellitus,endothelial cell,NDUFB5,"Which gene among TMEM14C, SMCR5, ATP2B2, NDUFB5, and MNX1 demonstrates the highest specificity in endothelial cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?""","Which gene among TMEM14C, SMCR5, ATP2B2, NDUFB5, and MNX1 demonstrates the highest specificity in endothelial cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?"" For type 1 diabetes mellitus, which verified therapeutic targets overlap with the endothelial cell-activated genes in PINNACLE? Retrieve the cell-type–specific embeddings for these overlapping targets, compute their average embedding as a reference, and calculate the cosine similarity between this reference and each target's embedding. Identify the gene with a markedly higher similarity than the others and provide a concise, evidence-based justification for its biological relevance as the top candidate."
"['MARCHF8', 'GON7', 'NDUFC2', 'MSI1', 'SLC4A5']",type 1 diabetes mellitus,endothelial cell,NDUFC2,"Which gene among MARCHF8, GON7, NDUFC2, MSI1, and SLC4A5 exhibits the highest endothelial cell-specific expression, making it the best candidate for targeting type 1 diabetes mellitus?","Which gene among MARCHF8, GON7, NDUFC2, MSI1, and SLC4A5 exhibits the highest endothelial cell-specific expression, making it the best candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which PINNACLE-identified endothelial cell-activated genes overlap with these targets and compute the average embedding for this overlapping set. Calculate the cosine similarity between this average embedding and each individual target gene’s embedding; if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief evidence-based explanation for its biological relevance."
"['LINC01962', 'PTGES3L', 'UPK3BL1', 'LINC01757', 'BRD2']",type 1 diabetes mellitus,endothelial cell,BRD2,"Among the genes LINC01962, PTGES3L, UPK3BL1, LINC01757, and BRD2, which exhibits the highest specificity for endothelial cells, making it the optimal candidate for targeted interventions in type 1 diabetes mellitus?","Among the genes LINC01962, PTGES3L, UPK3BL1, LINC01757, and BRD2, which exhibits the highest specificity for endothelial cells, making it the optimal candidate for targeted interventions in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Then, determine which endothelial cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific T1D targets. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ASAP1', 'CLEC4G', 'FBXO11', 'TMEM45B', 'TSPAN31']",type 1 diabetes mellitus,endothelial cell,ASAP1,"Which gene among ASAP1, CLEC4G, FBXO11, TMEM45B, and TSPAN31 exhibits the highest endothelial cell specificity relevant for targeting type 1 diabetes mellitus?","Which gene among ASAP1, CLEC4G, FBXO11, TMEM45B, and TSPAN31 exhibits the highest endothelial cell specificity relevant for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their associated cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets to define cell-type–specific targets for the disease. Calculate the average embedding for the overlapping gene set, then compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based rationale for its biological importance."
"['RNFT2', 'BRK1', 'MAP3K4-AS1', 'ADCY3', 'SCARA3']",type 1 diabetes mellitus,endothelial cell,ADCY3,"Which gene—RNFT2, BRK1, MAP3K4-AS1, ADCY3, or SCARA3—exhibits the highest specificity for endothelial cells in the context of type 1 diabetes mellitus, making it the most promising target for further investigation?","Which gene—RNFT2, BRK1, MAP3K4-AS1, ADCY3, or SCARA3—exhibits the highest specificity for endothelial cells in the context of type 1 diabetes mellitus, making it the most promising target for further investigation? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the endothelial cell–activated genes from PINNACLE overlap with these targets to define the cell-type–specific therapeutic targets. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual gene embedding. If one gene exhibits a distinctly higher similarity than the others, designate it as the top candidate, and provide a concise, evidence-based explanation for its biological relevance."
"['PPOX', 'IGFBP7', 'TSPO2', 'KCNK13', 'CFAP58-DT']",type 1 diabetes mellitus,endothelial cell,IGFBP7,"Among the genes PPOX, IGFBP7, TSPO2, KCNK13, and CFAP58-DT, which one demonstrates the highest specificity for endothelial cells and is the most promising candidate for targeting in type 1 diabetes mellitus?","Among the genes PPOX, IGFBP7, TSPO2, KCNK13, and CFAP58-DT, which one demonstrates the highest specificity for endothelial cells and is the most promising candidate for targeting in type 1 diabetes mellitus? Identify clinically validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in endothelial cells. For the overlapping set, compute the average embedding and then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['BCKDHA', 'MFN2', 'EIF4B', 'PCYOX1', 'MTCH1']",type 1 diabetes mellitus,endothelial cell,MTCH1,"Among the genes BCKDHA, MFN2, EIF4B, PCYOX1, and MTCH1, which one exhibits the highest endothelial cell specificity for targeted therapy in type 1 diabetes mellitus?","Among the genes BCKDHA, MFN2, EIF4B, PCYOX1, and MTCH1, which one exhibits the highest endothelial cell specificity for targeted therapy in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Among these, determine which targets overlap with genes activated in endothelial cells to define a set of cell-type–specific candidates. Compute the average embedding for this candidate set and calculate the cosine similarity between this average and the embedding of each individual gene. If one gene demonstrates markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYH7B', 'INS', 'CFAP46', 'TCF4-AS1', 'BACH1']",type 1 diabetes mellitus,endothelial cell,INS,"Among the genes MYH7B, INS, CFAP46, TCF4-AS1, and BACH1, which exhibits the highest specificity for endothelial cells in the context of targeting type 1 diabetes mellitus?","Among the genes MYH7B, INS, CFAP46, TCF4-AS1, and BACH1, which exhibits the highest specificity for endothelial cells in the context of targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the endothelial cell-activated genes in PINNACLE to define the cell-type-specific targets for T1D. Calculate the average embedding for this set and then determine the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SOX17', 'ZNF697', 'NYAP2', 'NDUFB2', 'PKIA']",type 1 diabetes mellitus,endothelial cell,NDUFB2,"Among SOX17, ZNF697, NYAP2, NDUFB2, and PKIA, which gene exhibits the highest specificity in endothelial cells for potentially targeting type 1 diabetes mellitus?","Among SOX17, ZNF697, NYAP2, NDUFB2, and PKIA, which gene exhibits the highest specificity in endothelial cells for potentially targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these therapeutic targets, yielding a refined set of cell-type–specific targets for type 1 diabetes. Compute the average embedding of this subset and calculate the cosine similarity between this average profile and each individual target embedding. Finally, if one gene displays a markedly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['VCX3B', 'PIAS2', 'CFAP53', 'ADGRE2', 'IL1R1']",type 1 diabetes mellitus,endothelial cell,IL1R1,"Among the candidate genes VCX3B, PIAS2, CFAP53, ADGRE2, and IL1R1, which exhibits the most endothelial cell-specific expression relevant to targeted interventions in type 1 diabetes mellitus?","Among the candidate genes VCX3B, PIAS2, CFAP53, ADGRE2, and IL1R1, which exhibits the most endothelial cell-specific expression relevant to targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific gene embeddings from PINNACLE. Next, determine which of the endothelial cell-activated genes in PINNACLE overlap with these targets; this overlapping set represents the cell-type–specific therapeutic targets for type 1 diabetes mellitus. Compute the average embedding for this set and then calculate the cosine similarity between the average embedding and each individual target's embedding. If one gene shows a significantly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NR3C1', 'WSB1', 'LINC02478', 'LINC01470', 'ZC3H13']",type 1 diabetes mellitus,endothelial cell,NR3C1,"Which gene among NR3C1, WSB1, LINC02478, LINC01470, and ZC3H13 exhibits the highest endothelial cell specificity for targeting type 1 diabetes mellitus?","Which gene among NR3C1, WSB1, LINC02478, LINC01470, and ZC3H13 exhibits the highest endothelial cell specificity for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of endothelial cell-activated genes in PINNACLE to define a subset of cell-type-specific targets for type 1 diabetes. Calculate the average embedding of this subset, then compute the cosine similarity between this average and the embedding of each target gene. If one gene shows a significantly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA12', 'GP6', 'LINC01219', 'XCL2', 'DDR2']",type 1 diabetes mellitus,endothelial cell,NDUFA12,"Which gene among NDUFA12, GP6, LINC01219, XCL2, and DDR2 demonstrates the highest endothelial cell expression specificity as a potential target for type 1 diabetes mellitus?","Which gene among NDUFA12, GP6, LINC01219, XCL2, and DDR2 demonstrates the highest endothelial cell expression specificity as a potential target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, among the endothelial cell-activated genes in this dataset, determine which overlap with these therapeutic targets. For these overlapping targets, compute their average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA3', 'HSPA1B', 'LRRC74A', 'AAMP', 'C1orf167-AS1']",type 1 diabetes mellitus,endothelial cell,NDUFA3,"Which gene among NDUFA3, HSPA1B, LRRC74A, AAMP, and C1orf167-AS1 exhibits the highest endothelial cell specificity for targeting type 1 diabetes mellitus?","Which gene among NDUFA3, HSPA1B, LRRC74A, AAMP, and C1orf167-AS1 exhibits the highest endothelial cell specificity for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the endothelial cell-activated genes in PINNACLE overlap with these targets to define the cell-specific targets for the disease. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TERC', 'LINC02026', 'LMLN', 'HLA-DRB1', 'ORC1']",type 1 diabetes mellitus,endothelial cell,HLA-DRB1,"Which gene among TERC, LINC02026, LMLN, HLA-DRB1, and ORC1 exhibits the most endothelial cell-specific expression for targeting type 1 diabetes mellitus?","Which gene among TERC, LINC02026, LMLN, HLA-DRB1, and ORC1 exhibits the most endothelial cell-specific expression for targeting type 1 diabetes mellitus? For type 1 diabetes mellitus, first identify the validated therapeutic target genes and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the endothelial cell-activated gene set from PINNACLE, and compute the average embedding for this overlapping group to serve as a reference. Then, calculate the cosine similarity between each individual gene’s embedding and the reference embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in type 1 diabetes mellitus."
"['LINC02498', 'CTRB1', 'GVQW3', 'LIMK1', 'GABRB3']",type 1 diabetes mellitus,endothelial cell,CTRB1,"Among LINC02498, CTRB1, GVQW3, LIMK1, and GABRB3, which gene exhibits the highest endothelial cell-specific expression, making it the optimal target for interventions in type 1 diabetes mellitus?","Among LINC02498, CTRB1, GVQW3, LIMK1, and GABRB3, which gene exhibits the highest endothelial cell-specific expression, making it the optimal target for interventions in type 1 diabetes mellitus? Identify the verified therapeutic target genes for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Identify the overlap with endothelial cell–activated genes in PINNACLE, and based on this intersection, compute an average embedding to serve as a reference. Then calculate the cosine similarity between this reference embedding and each individual gene's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EMD', 'TH2LCRR', 'MT-ND4', 'EFNB3', 'CKMT2']",type 1 diabetes mellitus,endothelial cell,MT-ND4,"Among the genes EMD, TH2LCRR, MT-ND4, EFNB3, and CKMT2, which one exhibits the highest endothelial cell-specific expression and represents the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes EMD, TH2LCRR, MT-ND4, EFNB3, and CKMT2, which one exhibits the highest endothelial cell-specific expression and represents the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type specific embeddings from PINNACLE. Then, determine which of these targets overlap with the endothelial cell-activated genes in PINNACLE to define a set of cell-type specific targets. Calculate the average embedding of this overlapping set as a reference, and compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['TRMT112', 'CTDP1', 'NDUFA11', 'PLCL2', 'TMEM233']",type 1 diabetes mellitus,endothelial cell,NDUFA11,"Among the genes TRMT112, CTDP1, NDUFA11, PLCL2, and TMEM233, which one exhibits the highest endothelial cell-type specificity for targeting in type 1 diabetes mellitus?","Among the genes TRMT112, CTDP1, NDUFA11, PLCL2, and TMEM233, which one exhibits the highest endothelial cell-type specificity for targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the endothelial cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding for this overlapping set as a reference vector, and then calculate the cosine similarity between the reference and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PFKL', 'GLRX2', 'STK38', 'ZBED3', 'OR8A1']",type 1 diabetes mellitus,unknown,PFKL,"Which gene among PFKL, GLRX2, STK38, ZBED3, and OR8A1 exhibits the highest degree of cell-type specific expression relevant for targeting type 1 diabetes mellitus?","Which gene among PFKL, GLRX2, STK38, ZBED3, and OR8A1 exhibits the highest degree of cell-type specific expression relevant for targeting type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which unknown-activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LILRB3', 'NHS', 'SMARCE1', 'PIAS1', 'LINC01482']",type 1 diabetes mellitus,unknown,SMARCE1,"Among the genes LILRB3, NHS, SMARCE1, PIAS1, and LINC01482, which exhibits the most pronounced cell-type-specific expression relevant for targeted intervention in type 1 diabetes mellitus?","Among the genes LILRB3, NHS, SMARCE1, PIAS1, and LINC01482, which exhibits the most pronounced cell-type-specific expression relevant for targeted intervention in type 1 diabetes mellitus? Identify the experimentally validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which genes labeled as ""unknown-activated"" in PINNACLE overlap with these targets, thus constituting the candidate cell-type–specific targets for the disease. Compute an average embedding from this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene displays substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['RNF216', 'METTL9', 'PIWIL1', 'CCDC171', 'KCTD17']",type 1 diabetes mellitus,unknown,RNF216,"Which gene among RNF216, METTL9, PIWIL1, CCDC171, and KCTD17 exhibits the highest cell type‐specific expression, making it the prime candidate for targeted studies in type 1 diabetes mellitus?","Which gene among RNF216, METTL9, PIWIL1, CCDC171, and KCTD17 exhibits the highest cell type‐specific expression, making it the prime candidate for targeted studies in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which unknown-activated genes in PINNACLE overlap with these targets to define the cell-type–specific candidate set. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual candidate. If one candidate shows a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PCDHA10', 'MAML2', 'TM4SF1', 'KANSL1', 'FAM167B']",type 1 diabetes mellitus,unknown,KANSL1,"Which gene—PCDHA10, MAML2, TM4SF1, KANSL1, or FAM167B—exhibits the highest cell-type specificity relevant to targeting type 1 diabetes mellitus?","Which gene—PCDHA10, MAML2, TM4SF1, KANSL1, or FAM167B—exhibits the highest cell-type specificity relevant to targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, using the set of activated but uncharacterized genes in PINNACLE, determine which of these overlap with the validated targets to define a cell-type–specific target set for type 1 diabetes. Compute the average embedding for these genes and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC22A18', 'CCDC74B', 'TBX5', 'TMEM117', 'GTF2IRD2']",type 1 diabetes mellitus,unknown,SLC22A18,"Which gene among SLC22A18, CCDC74B, TBX5, TMEM117, and GTF2IRD2 shows the most pronounced cell‐type-specific expression that could be relevant for targeting type 1 diabetes mellitus?","Which gene among SLC22A18, CCDC74B, TBX5, TMEM117, and GTF2IRD2 shows the most pronounced cell‐type-specific expression that could be relevant for targeting type 1 diabetes mellitus? Identify the confirmed therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes labeled as unknown-activated in PINNACLE overlap with these therapeutic targets to define the cell-type–specific targets for T1DM. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target. If a single gene demonstrates substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['EIF3A', 'PSRC1', 'LMO7', 'COX7A2L', 'ARHGEF37']",type 1 diabetes mellitus,unknown,LMO7,"Which gene among EIF3A, PSRC1, LMO7, COX7A2L, and ARHGEF37 demonstrates the highest degree of cell-type specificity, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among EIF3A, PSRC1, LMO7, COX7A2L, and ARHGEF37 demonstrates the highest degree of cell-type specificity, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the activated genes (currently unannotated) in PINNACLE overlap with these targets, thereby defining a set of cell-type–specific targets. Compute the average embedding for this set, then calculate the cosine similarity between this reference and each individual target embedding. Finally, nominate the gene with a markedly higher similarity as the top candidate, and provide a concise, evidence-based justification for its biological significance."
"['BTBD8', 'TNFRSF10A-AS1', 'TUSC3', 'SEC14L4', 'C2orf42']",type 1 diabetes mellitus,unknown,BTBD8,"Which gene among BTBD8, TNFRSF10A-AS1, TUSC3, SEC14L4, and C2orf42 exhibits the highest cell-type specific expression, thereby representing the most promising target for intervention in type 1 diabetes mellitus?","Which gene among BTBD8, TNFRSF10A-AS1, TUSC3, SEC14L4, and C2orf42 exhibits the highest cell-type specific expression, thereby representing the most promising target for intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which uncharacterized activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type–specific candidates for type 1 diabetes. Compute the average embedding for this candidate set and then calculate the cosine similarity between this average embedding and each individual target. Should one gene display a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['DENND10', 'NDUFA3', 'CUL3', 'SLC4A4', 'NUTM2D']",type 1 diabetes mellitus,unknown,NDUFA3,"Among the genes DENND10, NDUFA3, CUL3, SLC4A4, and NUTM2D, which one exhibits the highest cell-type specificity relevant for targeting type 1 diabetes mellitus?","Among the genes DENND10, NDUFA3, CUL3, SLC4A4, and NUTM2D, which one exhibits the highest cell-type specificity relevant for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, find which of the unknown-activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set. Calculate the average embedding for this set and then assess the cosine similarity between this average and each individual target embedding. If one gene shows a substantially higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LRRC37A3', 'HMGCR', 'MFSD13A', 'COBLL1', 'TRUB1']",type 1 diabetes mellitus,unknown,HMGCR,"Among the genes LRRC37A3, HMGCR, MFSD13A, COBLL1, and TRUB1, which one exhibits the most pronounced cell-type specificity for targeting in type 1 diabetes mellitus?","Among the genes LRRC37A3, HMGCR, MFSD13A, COBLL1, and TRUB1, which one exhibits the most pronounced cell-type specificity for targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the PINNACLE unknown-activated genes overlap with these targets, defining the cell-type–specific therapeutic candidates. Compute the average embedding of this candidate set and calculate the cosine similarity between this average and each candidate gene’s embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['LINC02080', 'TRDC', 'ZNF440', 'DNAJC13', 'FKBP1A']",type 1 diabetes mellitus,unknown,FKBP1A,"Among the genes LINC02080, TRDC, ZNF440, DNAJC13, and FKBP1A, which one exhibits the greatest cell-type specific expression relevant to targeting type 1 diabetes mellitus?","Among the genes LINC02080, TRDC, ZNF440, DNAJC13, and FKBP1A, which one exhibits the greatest cell-type specific expression relevant to targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the unknown-activated genes in PINNACLE overlap with these targets to define cell-type–specific therapeutic candidates. Compute the average embedding of these overlapping targets as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RANBP10', 'SRGAP1', 'RAB14', 'DDB2', 'FKBP9']",type 1 diabetes mellitus,unknown,RAB14,"Which gene among RANBP10, SRGAP1, RAB14, DDB2, and FKBP9 exhibits the highest cell-type-specific expression in tissues relevant to type 1 diabetes mellitus, making it the most promising candidate for targeted intervention?","Which gene among RANBP10, SRGAP1, RAB14, DDB2, and FKBP9 exhibits the highest cell-type-specific expression in tissues relevant to type 1 diabetes mellitus, making it the most promising candidate for targeted intervention? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the unknown-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of these overlapping targets and compute the cosine similarity between this average and each individual target embedding. If one gene shows significantly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FAM240B', 'DOCK9', 'LINC02827', 'PFDN5', 'MTMR3']",type 1 diabetes mellitus,unknown,MTMR3,"Among the candidate genes FAM240B, DOCK9, LINC02827, PFDN5, and MTMR3, which one exhibits the highest cell-type-specific expression and appears most promising as a therapeutic target for type 1 diabetes mellitus?","Among the candidate genes FAM240B, DOCK9, LINC02827, PFDN5, and MTMR3, which one exhibits the highest cell-type-specific expression and appears most promising as a therapeutic target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which unknown activated genes in PINNACLE overlap with these validated targets to form a set of cell-type–specific targets for type 1 diabetes. Compute the average embedding for this set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TTF1', 'BCAM', 'FAM163A', 'NDUFB3', 'PDZD7']",type 1 diabetes mellitus,unknown,NDUFB3,"Among TTF1, BCAM, FAM163A, NDUFB3, and PDZD7, which gene exhibits the most pronounced cell-type-specific expression in the target cell population implicated in type 1 diabetes mellitus?","Among TTF1, BCAM, FAM163A, NDUFB3, and PDZD7, which gene exhibits the most pronounced cell-type-specific expression in the target cell population implicated in type 1 diabetes mellitus? Using PINNACLE data, first identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings. Next, determine which of the genes predicted to be activated in PINNACLE overlap with these targets, forming a set of cell-type–specific targets. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual target embedding. Identify the gene with the highest cosine similarity as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['IGLVIVOR22-1', 'PLEKHM1', 'RSF1', 'CTAGE1', 'EMILIN2']",type 1 diabetes mellitus,unknown,PLEKHM1,"Among IGLVIVOR22-1, PLEKHM1, RSF1, CTAGE1, and EMILIN2, which gene shows the most pronounced cell-type-specific expression that could be leveraged as a target in type 1 diabetes mellitus?","Among IGLVIVOR22-1, PLEKHM1, RSF1, CTAGE1, and EMILIN2, which gene shows the most pronounced cell-type-specific expression that could be leveraged as a target in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell‐type–specific embeddings from the PINNACLE database. Next, determine which previously uncharacterized activated genes in PINNACLE intersect with these targets, thereby defining a set of cell‐type–specific targets for type 1 diabetes mellitus. Calculate the average embedding of these targets and compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TMEM187', 'FAR2', 'LINC01482', 'BSN', 'ZNF564']",type 1 diabetes mellitus,unknown,BSN,"Among the genes TMEM187, FAR2, LINC01482, BSN, and ZNF564, which one exhibits the highest cell-type specificity relevant to targeting type 1 diabetes mellitus?","Among the genes TMEM187, FAR2, LINC01482, BSN, and ZNF564, which one exhibits the highest cell-type specificity relevant to targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the unknown-activated genes in PINNACLE to define the cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set, and then compute the cosine similarity between this average and each individual target. If a single gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its potential relevance to type 1 diabetes mellitus."
"['GLRX5', 'LEXM', 'UBE2G1', 'ZNF257', 'LINC01897']",type 1 diabetes mellitus,unknown,UBE2G1,"Among the genes GLRX5, LEXM, UBE2G1, ZNF257, and LINC01897, which one displays the most pronounced cell-type-specific expression and represents the best candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes GLRX5, LEXM, UBE2G1, ZNF257, and LINC01897, which one displays the most pronounced cell-type-specific expression and represents the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic target genes for type 1 diabetes using PINNACLE and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and the PINNACLE-identified unknown-activated genes, which together form the prospective cell-type–specific targets for type 1 diabetes. Compute the average embedding of this subset to serve as a reference, and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RSBN1', 'HTR1D', 'LINC02186', 'THUMPD3', 'HOMER2']",type 1 diabetes mellitus,unknown,RSBN1,"Among RSBN1, HTR1D, LINC02186, THUMPD3, and HOMER2, which gene demonstrates the highest cell-type-specific expression in tissues relevant to type 1 diabetes mellitus, thereby representing the most promising candidate target?","Among RSBN1, HTR1D, LINC02186, THUMPD3, and HOMER2, which gene demonstrates the highest cell-type-specific expression in tissues relevant to type 1 diabetes mellitus, thereby representing the most promising candidate target? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which unknown-activated genes in PINNACLE overlap with these targets to define your cell-type–specific target set. Compute the average embedding for this set to serve as a reference, then calculate the cosine similarity between the reference and each individual gene. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['LIF-AS1', 'ASCL2', 'ZNF225', 'DIPK1B', 'ANXA4']",type 1 diabetes mellitus,unknown,ASCL2,"Which gene among LIF-AS1, ASCL2, ZNF225, DIPK1B, and ANXA4 exhibits the highest cell-type specificity in tissues relevant to type 1 diabetes mellitus, thereby serving as the optimal candidate for targeted intervention?","Which gene among LIF-AS1, ASCL2, ZNF225, DIPK1B, and ANXA4 exhibits the highest cell-type specificity in tissues relevant to type 1 diabetes mellitus, thereby serving as the optimal candidate for targeted intervention? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, intersect these targets with the unknown-activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding for this set and determine the cosine similarity between this average and each individual target embedding. Finally, if one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['DEFB124', 'DEXI', 'CNKSR1', 'RNASE3', 'ANKRD18A']",type 1 diabetes mellitus,unknown,DEXI,"Among the genes DEFB124, DEXI, CNKSR1, RNASE3, and ANKRD18A, which displays the highest cell-type specificity relevant to potential therapeutic targeting of type 1 diabetes mellitus?","Among the genes DEFB124, DEXI, CNKSR1, RNASE3, and ANKRD18A, which displays the highest cell-type specificity relevant to potential therapeutic targeting of type 1 diabetes mellitus? For type 1 diabetes mellitus, identify established therapeutic targets and extract their cell-type–specific embeddings from PINNACLE. Next, determine which activated but uncharacterized genes in PINNACLE overlap with these targets, forming a set of cell-type–specific candidates. Compute the average embedding for this candidate set and then calculate cosine similarity between this reference and each individual gene embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and briefly justify its biological relevance based on available evidence."
"['FBXL2', 'DIO3OS', 'BTN3A2', 'ZIM2', 'SYCE1L']",type 1 diabetes mellitus,unknown,BTN3A2,"Which gene among FBXL2, DIO3OS, BTN3A2, ZIM2, and SYCE1L exhibits the most cell-type-specific expression pattern, making it a promising candidate for targeted therapy in type 1 diabetes mellitus?","Which gene among FBXL2, DIO3OS, BTN3A2, ZIM2, and SYCE1L exhibits the most cell-type-specific expression pattern, making it a promising candidate for targeted therapy in type 1 diabetes mellitus? Using PINNACLE data, identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings. Next, determine which of the unknown-activated genes overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC00572', 'SAP130', 'ATP6V0C', 'ASXL3', 'SLC5A1']",type 1 diabetes mellitus,pancreatic a cell,SLC5A1,"Among the genes LINC00572, SAP130, ATP6V0C, ASXL3, and SLC5A1, which one demonstrates the highest cell-type specificity in pancreatic cells for targeted interventions in type 1 diabetes mellitus?","Among the genes LINC00572, SAP130, ATP6V0C, ASXL3, and SLC5A1, which one demonstrates the highest cell-type specificity in pancreatic cells for targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine which pancreatic alpha cell-activated genes in PINNACLE overlap with these targets, defining the cell-type-specific targets for the disease. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference vector and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TUBB2A', 'SCGN', 'PDE1A', 'RNF43', 'PCDHGA9']",type 1 diabetes mellitus,pancreatic a cell,SCGN,"Among the candidate genes TUBB2A, SCGN, PDE1A, RNF43, and PCDHGA9, which one exhibits the highest cell-type specificity in pancreatic alpha cells for targeting type 1 diabetes mellitus?","Among the candidate genes TUBB2A, SCGN, PDE1A, RNF43, and PCDHGA9, which one exhibits the highest cell-type specificity in pancreatic alpha cells for targeting type 1 diabetes mellitus? Identify and retrieve the cell-type–specific embeddings from PINNACLE for all verified therapeutic targets in type 1 diabetes mellitus. Next, determine which pancreatic alpha cell-activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this reference embedding and the embedding of each individual target gene. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OR4K17', 'C12orf60', 'PPP1R14B', 'ZNF789', 'MARK3']",type 1 diabetes mellitus,pancreatic a cell,PPP1R14B,"Which gene among OR4K17, C12orf60, PPP1R14B, ZNF789, and MARK3 exhibits the highest specificity for pancreatic alpha cells, making it the most suitable candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among OR4K17, C12orf60, PPP1R14B, ZNF789, and MARK3 exhibits the highest specificity for pancreatic alpha cells, making it the most suitable candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from PINNACLE. Then, determine which of these targets overlap with genetically activated pancreatic alpha-cell genes in PINNACLE, forming a set of cell-type-specific targets. Next, compute the average embedding for this set and calculate the cosine similarity between this reference and each individual target. Finally, if one target exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MTCH1', 'ADPGK-AS1', 'GCSAML', 'NETO1', 'PCDHB3']",type 1 diabetes mellitus,pancreatic a cell,MTCH1,"Which gene among MTCH1, ADPGK-AS1, GCSAML, NETO1, and PCDHB3 exhibits the highest specificity to pancreatic alpha cells as a potential target for type 1 diabetes mellitus?","Which gene among MTCH1, ADPGK-AS1, GCSAML, NETO1, and PCDHB3 exhibits the highest specificity to pancreatic alpha cells as a potential target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the pancreatic alpha cell–activated genes in PINNACLE, defining this overlap as the set of cell-type–specific T1DM targets. Compute the average embedding for this set, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AMZ2', 'COX7A2L', 'LHX4', 'RFTN2', 'TRAPPC3L']",type 1 diabetes mellitus,pancreatic a cell,AMZ2,"Among the genes AMZ2, COX7A2L, LHX4, RFTN2, and TRAPPC3L, which one exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes AMZ2, COX7A2L, LHX4, RFTN2, and TRAPPC3L, which one exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic alpha cells as recorded in PINNACLE. Compute the average embedding for this overlapping set, and then calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene shows notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ZSCAN5A-AS1', 'ZNF165', 'SCAND1', 'TMEM104', 'HIBCH']",type 1 diabetes mellitus,pancreatic a cell,ZNF165,"Which gene among ZSCAN5A-AS1, ZNF165, SCAND1, TMEM104, and HIBCH exhibits the highest cell-type specificity in pancreatic alpha cells for potential targeting in type 1 diabetes mellitus interventions?","Which gene among ZSCAN5A-AS1, ZNF165, SCAND1, TMEM104, and HIBCH exhibits the highest cell-type specificity in pancreatic alpha cells for potential targeting in type 1 diabetes mellitus interventions? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic alpha cell-activated genes in PINNACLE overlap with these targets to obtain a set of cell-type–specific targets for type 1 diabetes. Compute the average embedding for this set and calculate the cosine similarity between this reference and the embedding for each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPS28', 'CCDC190', 'HMGCR', 'EFCAB6-AS1', 'NMB']",type 1 diabetes mellitus,pancreatic a cell,HMGCR,"Which gene among RPS28, CCDC190, HMGCR, EFCAB6-AS1, and NMB exhibits the highest specificity for pancreatic alpha cells as a potential target in type 1 diabetes mellitus?","Which gene among RPS28, CCDC190, HMGCR, EFCAB6-AS1, and NMB exhibits the highest specificity for pancreatic alpha cells as a potential target in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of pancreatic α-cell–activated genes in PINNACLE to define the cell-type-specific targets. Compute the average embedding for this subset and calculate the cosine similarity between this reference vector and the embedding of each individual target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['CCDC57', 'RIN1', 'NDUFA7', 'UGT2B17', 'ABCC11']",type 1 diabetes mellitus,pancreatic a cell,NDUFA7,"Among the genes CCDC57, RIN1, NDUFA7, UGT2B17, and ABCC11, which one exhibits the highest specificity to pancreatic alpha cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes CCDC57, RIN1, NDUFA7, UGT2B17, and ABCC11, which one exhibits the highest specificity to pancreatic alpha cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of genes activated in pancreatic α cells as defined in PINNACLE to establish a refined list of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference vector, then calculate the cosine similarity between this reference and each target's individual embedding. If one gene exhibits a significantly higher similarity score compared to the others, nominate it as the top candidate and provide a brief, evidence-supported rationale for its biological relevance."
"['AP3B2', 'MPZL2', 'GCA', 'C11orf58', 'IGHGP']",type 1 diabetes mellitus,pancreatic a cell,GCA,"Which gene among AP3B2, MPZL2, GCA, C11orf58, and IGHGP demonstrates the highest cell‐type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among AP3B2, MPZL2, GCA, C11orf58, and IGHGP demonstrates the highest cell‐type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic alpha cell–activated genes in PINNACLE. Using the overlapping set as the cell-type–specific targets for type 1 diabetes, compute their average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NUDT15', 'NDUFA11', 'NPIPB2', 'UBXN2B', 'SLITRK4']",type 1 diabetes mellitus,pancreatic a cell,NDUFA11,"Which gene among NUDT15, NDUFA11, NPIPB2, UBXN2B, and SLITRK4 exhibits the highest expression specificity in pancreatic alpha cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among NUDT15, NDUFA11, NPIPB2, UBXN2B, and SLITRK4 exhibits the highest expression specificity in pancreatic alpha cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic α-cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of these overlapping genes to establish a reference, then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['GCAT', 'FAM83F', 'CD44', 'CDK10', 'LINC00870']",type 1 diabetes mellitus,pancreatic a cell,CD44,"Which gene among GCAT, FAM83F, CD44, CDK10, and LINC00870 exhibits the highest specificity for pancreatic cells, thereby representing the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among GCAT, FAM83F, CD44, CDK10, and LINC00870 exhibits the highest specificity for pancreatic cells, thereby representing the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify the known therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic α cell–activated gene set in PINNACLE; this overlapping set represents cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this set and then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LINC01187', 'GCDH', 'UBE2E2', 'RAB14', 'LACTB2']",type 1 diabetes mellitus,pancreatic a cell,RAB14,"Among LINC01187, GCDH, UBE2E2, RAB14, and LACTB2, which gene demonstrates the highest specificity for pancreatic alpha cells in the context of targeting type 1 diabetes mellitus?","Among LINC01187, GCDH, UBE2E2, RAB14, and LACTB2, which gene demonstrates the highest specificity for pancreatic alpha cells in the context of targeting type 1 diabetes mellitus? Identify all experimentally verified therapeutic targets for type 1 diabetes mellitus and obtain their cell type–specific embeddings from PINNACLE. Next, determine which pancreatic alpha cell–activated genes overlap with these therapeutic targets to define a set of cell type–specific candidates. Calculate the average embedding for this candidate set and then compute the cosine similarity between this average and each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['GTF3C6', 'C6orf136', 'BATF2', 'PFN4', 'UNC80']",type 1 diabetes mellitus,pancreatic a cell,C6orf136,"Which gene among GTF3C6, C6orf136, BATF2, PFN4, and UNC80 exhibits the highest specificity for pancreatic alpha cells, thereby representing the most promising target for type 1 diabetes mellitus interventions?","Which gene among GTF3C6, C6orf136, BATF2, PFN4, and UNC80 exhibits the highest specificity for pancreatic alpha cells, thereby representing the most promising target for type 1 diabetes mellitus interventions? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the pancreatic α-cell–activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of these overlapping targets and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['C20orf203', 'CCT5', 'ATF6B', 'TMEM44-AS1', 'PNO1']",type 1 diabetes mellitus,pancreatic a cell,ATF6B,"Which gene among C20orf203, CCT5, ATF6B, TMEM44-AS1, and PNO1 exhibits the highest specificity for pancreatic alpha cells and represents the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among C20orf203, CCT5, ATF6B, TMEM44-AS1, and PNO1 exhibits the highest specificity for pancreatic alpha cells and represents the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic α cell–activated genes from PINNACLE overlap with these targets to define a set of cell-type–specific therapeutic candidates for type 1 diabetes mellitus. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each gene’s embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CYP51A1-AS1', 'EFEMP2', 'SMIM22', 'NDUFAF1', 'RBSN']",type 1 diabetes mellitus,pancreatic a cell,NDUFAF1,"Among the genes CYP51A1-AS1, EFEMP2, SMIM22, NDUFAF1, and RBSN, which one exhibits the highest cell-type specificity in pancreatic alpha cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes CYP51A1-AS1, EFEMP2, SMIM22, NDUFAF1, and RBSN, which one exhibits the highest cell-type specificity in pancreatic alpha cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic alpha cells according to PINNACLE data. For the overlapping set, compute the average embedding vector to serve as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IKZF4', 'PDE7A', 'STC2', 'GOLGA8N', 'ZFP69B']",type 1 diabetes mellitus,pancreatic a cell,IKZF4,"Among the genes IKZF4, PDE7A, STC2, GOLGA8N, and ZFP69B, which demonstrates the highest specificity for pancreatic alpha cells, making it the optimal candidate for targeting type 1 diabetes mellitus?","Among the genes IKZF4, PDE7A, STC2, GOLGA8N, and ZFP69B, which demonstrates the highest specificity for pancreatic alpha cells, making it the optimal candidate for targeting type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from the PINNACLE dataset. Next, cross-reference these targets with the set of pancreatic α cell-activated genes from PINNACLE to define a subset of cell-type-specific targets for type 1 diabetes. Calculate the average embedding for this subset and determine the cosine similarity between this average embedding and each individual target. Finally, nominate the gene with a markedly higher cosine similarity than the others as the top candidate, and provide a concise, evidence-based explanation for its biological relevance."
"['DDR1', 'SLC35B1', 'CPSF4L', 'ARL8A', 'KLHDC3']",type 1 diabetes mellitus,pancreatic a cell,DDR1,"Which gene among DDR1, SLC35B1, CPSF4L, ARL8A, and KLHDC3 shows the highest cell-type specificity in pancreatic alpha cells, making it the best candidate for targeting type 1 diabetes mellitus?","Which gene among DDR1, SLC35B1, CPSF4L, ARL8A, and KLHDC3 shows the highest cell-type specificity in pancreatic alpha cells, making it the best candidate for targeting type 1 diabetes mellitus? Identify the experimentally validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in pancreatic alpha cells overlap with these targets, defining a set of cell-type–specific targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and the embedding of each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['UBE2G1', 'LINC02037', 'MAP3K13', 'PKIA', 'ZSCAN20']",type 1 diabetes mellitus,pancreatic a cell,UBE2G1,"Which gene among UBE2G1, LINC02037, MAP3K13, PKIA, and ZSCAN20 exhibits the highest cell-type specificity in pancreatic alpha cells, thereby representing the most promising target for type 1 diabetes mellitus interventions?","Which gene among UBE2G1, LINC02037, MAP3K13, PKIA, and ZSCAN20 exhibits the highest cell-type specificity in pancreatic alpha cells, thereby representing the most promising target for type 1 diabetes mellitus interventions? Identify validated therapeutic targets for type 1 diabetes and extract their cell-type–specific embeddings from the PINNACLE database. Next, find the overlap between these targets and the pancreatic α cell-activated genes in PINNACLE, as this intersection represents the cell-type–specific targets for type 1 diabetes. Compute the average embedding for the overlapping genes to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DOK1', 'MT-ND4L', 'PLUT', 'CREB3L1', 'PFKP']",type 1 diabetes mellitus,pancreatic a cell,MT-ND4L,"Which gene among DOK1, MT-ND4L, PLUT, CREB3L1, and PFKP demonstrates the highest specificity for pancreatic α cells, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus?","Which gene among DOK1, MT-ND4L, PLUT, CREB3L1, and PFKP demonstrates the highest specificity for pancreatic α cells, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic α-cell–activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping gene set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAGEL2', 'NDUFA12', 'IDH3B', 'DAPK1', 'CDH23']",type 1 diabetes mellitus,pancreatic a cell,NDUFA12,"Among the genes MAGEL2, NDUFA12, IDH3B, DAPK1, and CDH23, which exhibits the highest cell-type specificity in pancreatic alpha cells for potential therapeutic targeting of type 1 diabetes mellitus?","Among the genes MAGEL2, NDUFA12, IDH3B, DAPK1, and CDH23, which exhibits the highest cell-type specificity in pancreatic alpha cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the pancreatic alpha-cell–activated genes in PINNACLE. Using this overlapping set, compute the average embedding as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RAB5IF', 'CA7', 'TRNP1', 'SNAPC3', 'CLEC2B']",type 1 diabetes mellitus,pancreatic stellate cell,CLEC2B,"Which gene out of RAB5IF, CA7, TRNP1, SNAPC3, and CLEC2B exhibits the highest cell-type specificity in pancreatic stellate cells relevant to type 1 diabetes mellitus intervention?","Which gene out of RAB5IF, CA7, TRNP1, SNAPC3, and CLEC2B exhibits the highest cell-type specificity in pancreatic stellate cells relevant to type 1 diabetes mellitus intervention? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic stellate cells as indicated in PINNACLE. Calculate the average embedding of the overlapping targets, then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['BBS5', 'ETFB', 'RASSF9', 'PCDHA5', 'RHOA']",type 1 diabetes mellitus,pancreatic stellate cell,RHOA,"Among the genes BBS5, ETFB, RASSF9, PCDHA5, and RHOA, which one exhibits the most cell-type specific expression in pancreatic stellate cells to serve as a potential target for type 1 diabetes mellitus?","Among the genes BBS5, ETFB, RASSF9, PCDHA5, and RHOA, which one exhibits the most cell-type specific expression in pancreatic stellate cells to serve as a potential target for type 1 diabetes mellitus? Retrieve the cell-type–specific embeddings from PINNACLE for all validated therapeutic targets of type 1 diabetes mellitus. Identify the overlap between these targets and genes activated in pancreatic stellate cells to generate a set of cell-type–specific diabetes targets. Compute the average embedding for this subset, and then calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TINCR', 'FLOT1', 'PGM1', 'DCUN1D2', 'SMC1B']",type 1 diabetes mellitus,pancreatic stellate cell,PGM1,"Among TINCR, FLOT1, PGM1, DCUN1D2, and SMC1B, which gene exhibits the highest cell-type specificity in pancreatic stellate cells for potential therapeutic targeting in type 1 diabetes mellitus?","Among TINCR, FLOT1, PGM1, DCUN1D2, and SMC1B, which gene exhibits the highest cell-type specificity in pancreatic stellate cells for potential therapeutic targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Determine which of these targets overlap with the set of pancreatic stellate cell–activated genes in PINNACLE. Compute the average embedding of the overlapping targets as a reference profile and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SEZ6L', 'PTGFR', 'MYH4', 'NRXN2', 'FOXN3']",type 1 diabetes mellitus,pancreatic stellate cell,FOXN3,"Which gene among SEZ6L, PTGFR, MYH4, NRXN2, and FOXN3 exhibits the highest cell-type specificity in pancreatic stellate cells, thereby serving as the most promising target for type 1 diabetes mellitus?","Which gene among SEZ6L, PTGFR, MYH4, NRXN2, and FOXN3 exhibits the highest cell-type specificity in pancreatic stellate cells, thereby serving as the most promising target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their corresponding cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic stellate cell-activated genes in PINNACLE. For this overlapping set, calculate the average embedding to serve as a reference, then compute the cosine similarity between this reference and each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ADCY3', 'RPL37', 'CDCA7', 'ATP13A2', 'ZNF667']",type 1 diabetes mellitus,pancreatic stellate cell,ADCY3,"Among ADCY3, RPL37, CDCA7, ATP13A2, and ZNF667, which gene exhibits the highest cell-type specific expression in pancreatic stellate cells, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus?","Among ADCY3, RPL37, CDCA7, ATP13A2, and ZNF667, which gene exhibits the highest cell-type specific expression in pancreatic stellate cells, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of pancreatic stellate cell-activated genes in PINNACLE. Calculate the average embedding for this overlapping subset as a reference, and then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity score compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AMZ2', 'R3HDM2', 'TFB1M', 'EPB41L4A-DT', 'TEF']",type 1 diabetes mellitus,pancreatic stellate cell,AMZ2,"Among the genes AMZ2, R3HDM2, TFB1M, EPB41L4A-DT, and TEF, which one exhibits the highest cell-type specificity in pancreatic stellate cells for potential therapeutic targeting of type 1 diabetes mellitus?","Among the genes AMZ2, R3HDM2, TFB1M, EPB41L4A-DT, and TEF, which one exhibits the highest cell-type specificity in pancreatic stellate cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes expressed by activated pancreatic stellate cells in PINNACLE. Calculate the average embedding for this overlapping gene set and then assess the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EID1', 'APOBEC3G', 'LINC01732', 'LINC01684', 'GSTA3']",type 1 diabetes mellitus,pancreatic stellate cell,EID1,"Among EID1, APOBEC3G, LINC01732, LINC01684, and GSTA3, which gene exhibits the highest cell-type specificity in pancreatic stellate cells for its potential role in targeting type 1 diabetes mellitus?","Among EID1, APOBEC3G, LINC01732, LINC01684, and GSTA3, which gene exhibits the highest cell-type specificity in pancreatic stellate cells for its potential role in targeting type 1 diabetes mellitus? What are the verified therapeutic targets for type 1 diabetes mellitus, and what are their cell-type–specific embeddings from PINNACLE? Identify the overlap between these targets and the genes activated in pancreatic stellate cells within PINNACLE. For this overlapping set, calculate the average embedding as a reference and then compute the cosine similarity between each individual target and this reference. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SH2B3', 'CHRND', 'NAA38', 'ASIC4-AS1', 'P2RX1']",type 1 diabetes mellitus,pancreatic stellate cell,SH2B3,"Which gene among SH2B3, CHRND, NAA38, ASIC4-AS1, and P2RX1 exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Which gene among SH2B3, CHRND, NAA38, ASIC4-AS1, and P2RX1 exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify recognized therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and pancreatic stellate cell-activated genes in PINNACLE. For the overlapping set, compute the average embedding and calculate the cosine similarity between this average and each individual gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C1orf21-DT', 'KBTBD11', 'SH3YL1', 'PRMT9', 'GSN']",type 1 diabetes mellitus,pancreatic stellate cell,GSN,"Among the genes C1orf21-DT, KBTBD11, SH3YL1, PRMT9, and GSN, which one exhibits the highest cell-type specificity in pancreatic stellate cells for developing targeted interventions for type 1 diabetes mellitus?","Among the genes C1orf21-DT, KBTBD11, SH3YL1, PRMT9, and GSN, which one exhibits the highest cell-type specificity in pancreatic stellate cells for developing targeted interventions for type 1 diabetes mellitus? Determine the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlap with the pancreatic stellate cell-activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of these targets as a reference, then assess the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CYRIA', 'F2R', 'ZNF133', 'CYP4F11', 'TMEM41B']",type 1 diabetes mellitus,pancreatic stellate cell,F2R,"Among the genes CYRIA, F2R, ZNF133, CYP4F11, and TMEM41B, which one exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Among the genes CYRIA, F2R, ZNF133, CYP4F11, and TMEM41B, which one exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic stellate cell-activated genes in PINNACLE. For this overlapping set, calculate the average embedding and then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['COPZ2', 'PIDD1', 'LINC02200', 'SNX31', 'SLC2A14']",type 1 diabetes mellitus,pancreatic stellate cell,COPZ2,"Among the genes COPZ2, PIDD1, LINC02200, SNX31, and SLC2A14, which one exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising target for type 1 diabetes mellitus?","Among the genes COPZ2, PIDD1, LINC02200, SNX31, and SLC2A14, which one exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising target for type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlapping genes between these targets and the set of pancreatic stellate cell–activated genes in PINNACLE to define the cell-type–specific targets. Calculate the average embedding for this group and then compute the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits substantially higher similarity compared to the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological importance."
"['CTIF', 'ZNF644', 'CLK4', 'CD44', 'NOC4L']",type 1 diabetes mellitus,pancreatic stellate cell,CD44,"Which gene—CTIF, ZNF644, CLK4, CD44, or NOC4L—exhibits the most cell type-specific expression in pancreatic stellate cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus?","Which gene—CTIF, ZNF644, CLK4, CD44, or NOC4L—exhibits the most cell type-specific expression in pancreatic stellate cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic stellate cell–activated genes in PINNACLE, as this intersection defines the cell-type–specific targets for the disease. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based explanation of its biological relevance."
"['ZNF562', 'SMIM30', 'CNTN6', 'PCAT14', 'TNS1-AS1']",type 1 diabetes mellitus,pancreatic stellate cell,SMIM30,"Which gene among ZNF562, SMIM30, CNTN6, PCAT14, and TNS1-AS1 exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among ZNF562, SMIM30, CNTN6, PCAT14, and TNS1-AS1 exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, identify the subset of these targets that overlaps with genes activated in pancreatic stellate cells in PINNACLE. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OSBPL3', 'CTDNEP1', 'HCG25', 'LINC01182', 'CCDC17']",type 1 diabetes mellitus,pancreatic stellate cell,CTDNEP1,"Among the genes OSBPL3, CTDNEP1, HCG25, LINC01182, and CCDC17, which one exhibits the highest cell-type specificity in pancreatic stellate cells as a potential therapeutic target for type 1 diabetes mellitus?","Among the genes OSBPL3, CTDNEP1, HCG25, LINC01182, and CCDC17, which one exhibits the highest cell-type specificity in pancreatic stellate cells as a potential therapeutic target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus using PINNACLE and retrieve their cell-type–specific embeddings. Next, determine which pancreatic stellate cell–activated genes in PINNACLE overlap with these targets. Calculate the average embedding for the overlapping set and compute the cosine similarity between this average and each individual target gene's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MIR9-3HG', 'ABHD2', 'LTBP1', 'CCNJL', 'MALRD1']",type 1 diabetes mellitus,pancreatic stellate cell,LTBP1,"Among the genes MIR9-3HG, ABHD2, LTBP1, CCNJL, and MALRD1, which one exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Among the genes MIR9-3HG, ABHD2, LTBP1, CCNJL, and MALRD1, which one exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the pancreatic stellate cell–activated genes in PINNACLE overlap with those targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF408', 'SP5', 'EBF1', 'AGRN', 'LINC01132']",type 1 diabetes mellitus,pancreatic stellate cell,EBF1,"Which one of the following genes—ZNF408, SP5, EBF1, AGRN, or LINC01132—is most specifically expressed in pancreatic stellate cells, thereby representing the best candidate for targeted intervention in type 1 diabetes mellitus?","Which one of the following genes—ZNF408, SP5, EBF1, AGRN, or LINC01132—is most specifically expressed in pancreatic stellate cells, thereby representing the best candidate for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify the intersection of these targets with pancreatic stellate cell–activated genes from PINNACLE, yielding cell-type–specific T1DM targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target. Finally, nominate the gene with a markedly higher similarity as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['ASAP1', 'SPRY4-AS1', 'MMP23B', 'C4orf36', 'HNRNPL']",type 1 diabetes mellitus,pancreatic stellate cell,ASAP1,"Among the genes ASAP1, SPRY4-AS1, MMP23B, C4orf36, and HNRNPL, which exhibits the highest specificity for expression in pancreatic stellate cells and holds the greatest potential as a therapeutic target in type 1 diabetes mellitus?","Among the genes ASAP1, SPRY4-AS1, MMP23B, C4orf36, and HNRNPL, which exhibits the highest specificity for expression in pancreatic stellate cells and holds the greatest potential as a therapeutic target in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic stellate cell–activated genes in PINNACLE. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based explanation for its biological relevance."
"['BRD2', 'KLHL35', 'LINC00452', 'CACNA1C-AS1', 'ST6GALNAC3']",type 1 diabetes mellitus,pancreatic stellate cell,BRD2,"Among the genes BRD2, KLHL35, LINC00452, CACNA1C-AS1, and ST6GALNAC3, which shows the highest cell-type specific expression in pancreatic stellate cells as a candidate target for type 1 diabetes mellitus?","Among the genes BRD2, KLHL35, LINC00452, CACNA1C-AS1, and ST6GALNAC3, which shows the highest cell-type specific expression in pancreatic stellate cells as a candidate target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the pancreatic stellate cell–activated genes in PINNACLE to define the cell-type–specific targets for the disease. Calculate the average embedding for these overlapping genes, then assess the cosine similarity between this average and the embedding for each individual target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['KIAA0930', 'NPHP3-AS1', 'DMKN', 'STEAP1', 'EPB41L4B']",type 1 diabetes mellitus,pancreatic stellate cell,STEAP1,"Among the genes KIAA0930, NPHP3-AS1, DMKN, STEAP1, and EPB41L4B, which one exhibits the highest specificity of expression in pancreatic stellate cells and thus represents the best candidate for targeting type 1 diabetes mellitus?","Among the genes KIAA0930, NPHP3-AS1, DMKN, STEAP1, and EPB41L4B, which one exhibits the highest specificity of expression in pancreatic stellate cells and thus represents the best candidate for targeting type 1 diabetes mellitus? Determine the validated therapeutic targets for type 1 diabetes mellitus from PINNACLE and extract their cell-type–specific embeddings. Next, identify which targets are also pancreatic stellate cell–activated genes in PINNACLE to form an overlapping set. Compute the average embedding for this set and then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TCAF2', 'HUWE1', 'MYL6', 'GTF3C2', 'CDK5RAP3']",type 1 diabetes mellitus,pancreatic stellate cell,CDK5RAP3,"Among the genes TCAF2, HUWE1, MYL6, GTF3C2, and CDK5RAP3, which one exhibits the highest specificity for pancreatic stellate cells, making it the most suitable candidate for targeting in type 1 diabetes mellitus?","Among the genes TCAF2, HUWE1, MYL6, GTF3C2, and CDK5RAP3, which one exhibits the highest specificity for pancreatic stellate cells, making it the most suitable candidate for targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with pancreatic stellate cell-activated genes in PINNACLE. For the overlapping genes, compute the average embedding to serve as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CNTN2', 'NT5DC2', 'TAP2', 'ZMAT2', 'DCAF5']",type 1 diabetes mellitus,pancreatic acinar cell,TAP2,"Among CNTN2, NT5DC2, TAP2, ZMAT2, and DCAF5, which gene exhibits the highest cell-type specificity in pancreatic acinar cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among CNTN2, NT5DC2, TAP2, ZMAT2, and DCAF5, which gene exhibits the highest cell-type specificity in pancreatic acinar cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic acinar cells. Compute the average embedding of this overlapping set as a reference vector, then calculate the cosine similarity between the reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LYPD5', 'UHMK1', 'FBRS', 'LINC01793', 'TUFM']",type 1 diabetes mellitus,pancreatic acinar cell,TUFM,"Among the following genes—LYPD5, UHMK1, FBRS, LINC01793, and TUFM—which one exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the following genes—LYPD5, UHMK1, FBRS, LINC01793, and TUFM—which one exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the confirmed therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection of these targets with the set of pancreatic acinar cell–activated genes in PINNACLE to define cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['EPHA1-AS1', 'GIT2', 'ARMC5', 'APBA2', 'NDUFS3']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFS3,"Among the genes EPHA1-AS1, GIT2, ARMC5, APBA2, and NDUFS3, which one displays the highest cell-type specificity in pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus research?","Among the genes EPHA1-AS1, GIT2, ARMC5, APBA2, and NDUFS3, which one displays the highest cell-type specificity in pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus research? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic acinar cell‐activated genes in PINNACLE. Compute the average embedding of the overlapping set, then calculate the cosine similarity between this composite embedding and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TTN-AS1', 'MIR378D2HG', 'CUTA', 'ZNF443', 'PCDH15']",type 1 diabetes mellitus,pancreatic acinar cell,CUTA,"Among the genes TTN-AS1, MIR378D2HG, CUTA, ZNF443, and PCDH15, which one shows the most specific expression in pancreatic acinar cells, thereby representing the best candidate for targeting type 1 diabetes mellitus?","Among the genes TTN-AS1, MIR378D2HG, CUTA, ZNF443, and PCDH15, which one shows the most specific expression in pancreatic acinar cells, thereby representing the best candidate for targeting type 1 diabetes mellitus? Identify the therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and the pancreatic acinar cell-activated genes defined in PINNACLE, and compute the average embedding of this overlapping set. Then, calculate the cosine similarity between this average reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the prime candidate, and provide a concise, evidence-based explanation for its biological significance."
"['SHROOM3', 'RAB8A', 'RAF1', 'C5AR2', 'TMSB4X']",type 1 diabetes mellitus,pancreatic acinar cell,RAF1,"Which gene among SHROOM3, RAB8A, RAF1, C5AR2, and TMSB4X exhibits the highest specificity for pancreatic acinar cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among SHROOM3, RAB8A, RAF1, C5AR2, and TMSB4X exhibits the highest specificity for pancreatic acinar cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Determine the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and genes activated in pancreatic acinar cells to define a subset of cell-type–specific targets. Compute the average embedding of this subset as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['KLK10', 'BRD2', 'DUS1L', 'CETN3', 'ARL4C']",type 1 diabetes mellitus,pancreatic acinar cell,BRD2,"Which gene among KLK10, BRD2, DUS1L, CETN3, and ARL4C demonstrates the highest cell-type specificity in pancreatic acinar cells for potential targeting in type 1 diabetes mellitus?","Which gene among KLK10, BRD2, DUS1L, CETN3, and ARL4C demonstrates the highest cell-type specificity in pancreatic acinar cells for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which genes activated in pancreatic acinar cells overlap with these targets. Use the average embedding of the overlapping set as a reference to calculate the cosine similarity for each target. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BORCS6', 'ZBTB46', 'C12orf56', 'ESYT1', 'ZNF675']",type 1 diabetes mellitus,pancreatic acinar cell,ESYT1,"Which gene among BORCS6, ZBTB46, C12orf56, ESYT1, and ZNF675 exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeted research on type 1 diabetes mellitus?","Which gene among BORCS6, ZBTB46, C12orf56, ESYT1, and ZNF675 exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeted research on type 1 diabetes mellitus? Identify experimentally validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which genes activated in pancreatic acinar cells overlap with these targets, defining a set of cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based explanation of its biological relevance."
"['EID1', 'LILRA5', 'IL10RB-DT', 'KIAA2026', 'PBLD']",type 1 diabetes mellitus,pancreatic acinar cell,EID1,"Which gene among EID1, LILRA5, IL10RB-DT, KIAA2026, and PBLD exhibits the highest cell-type specificity in pancreatic acinar cells relevant to targeting type 1 diabetes mellitus?","Which gene among EID1, LILRA5, IL10RB-DT, KIAA2026, and PBLD exhibits the highest cell-type specificity in pancreatic acinar cells relevant to targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic acinar cell–activated genes listed in PINNACLE. Compute the average embedding for this overlapping set, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIC', 'FAM83C-AS1', 'DDN', 'CNTNAP2', 'NDUFB3']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFB3,"Which gene among PPIC, FAM83C-AS1, DDN, CNTNAP2, and NDUFB3 exhibits the highest specificity in pancreatic acinar cells and may serve as a potential target for type 1 diabetes mellitus?","Which gene among PPIC, FAM83C-AS1, DDN, CNTNAP2, and NDUFB3 exhibits the highest specificity in pancreatic acinar cells and may serve as a potential target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine which of the pancreatic acinar cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific therapeutic targets. Compute the average embedding for this overlapping set, and calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HPDL', 'SRXN1', 'TAPBP', 'INSL6', 'IGLCOR22-1']",type 1 diabetes mellitus,pancreatic acinar cell,TAPBP,"Which gene among HPDL, SRXN1, TAPBP, INSL6, and IGLCOR22-1 exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus?","Which gene among HPDL, SRXN1, TAPBP, INSL6, and IGLCOR22-1 exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus? Retrieve the cell-type–specific embeddings from PINNACLE for all verified therapeutic targets of type 1 diabetes mellitus (T1DM). Identify the subset of these targets that overlaps with the pancreatic acinar cell-activated genes listed in PINNACLE. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and the embedding of each individual target. If one target displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in T1DM."
"['LINC00491', 'IMPDH2', 'C9orf24', 'LINC01363', 'SMCR8']",type 1 diabetes mellitus,pancreatic acinar cell,IMPDH2,"Among the following genes—LINC00491, IMPDH2, C9orf24, LINC01363, and SMCR8—which one exhibits the highest specificity for pancreatic acinar cells as a potential target in type 1 diabetes mellitus?","Among the following genes—LINC00491, IMPDH2, C9orf24, LINC01363, and SMCR8—which one exhibits the highest specificity for pancreatic acinar cells as a potential target in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the pancreatic acinar cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ABHD5', 'B3GNT9', 'SPTY2D1', 'MTMR3', 'ARHGAP44']",type 1 diabetes mellitus,pancreatic acinar cell,MTMR3,"Which gene among ABHD5, B3GNT9, SPTY2D1, MTMR3, and ARHGAP44 demonstrates the highest cell-type specificity in pancreatic acinar cells, making it a prime candidate for targeting type 1 diabetes mellitus?","Which gene among ABHD5, B3GNT9, SPTY2D1, MTMR3, and ARHGAP44 demonstrates the highest cell-type specificity in pancreatic acinar cells, making it a prime candidate for targeting type 1 diabetes mellitus? Identify established therapeutic targets for type 1 diabetes mellitus and extract their cell-type specific embeddings from the PINNACLE database. Determine which of these targets overlap with genes activated in pancreatic acinar cells, thereby defining the cell-type specific targets for type 1 diabetes. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference vector and the embedding of each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DIS3L', 'LHX4', 'PSMD11', 'HMG20A', 'FKRP']",type 1 diabetes mellitus,pancreatic acinar cell,FKRP,"Among the candidate genes DIS3L, LHX4, PSMD11, HMG20A, and FKRP, which one exhibits the highest cell-type–specific expression in pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus intervention?","Among the candidate genes DIS3L, LHX4, PSMD11, HMG20A, and FKRP, which one exhibits the highest cell-type–specific expression in pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus intervention? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with genes activated in pancreatic acinar cells, and compute the average embedding for this intersecting set. Then, calculate the cosine similarity between the average embedding and each individual target embedding. If one gene shows notably higher similarity compared to the others, nominate it as the primary candidate, including a concise, evidence-based explanation of its biological significance."
"['EMILIN2', 'SLC25A21', 'MED20', 'FSD1', 'TMEM14A']",type 1 diabetes mellitus,pancreatic acinar cell,SLC25A21,"Among the genes EMILIN2, SLC25A21, MED20, FSD1, and TMEM14A, which exhibits the highest cell-type specificity in pancreatic acinar cells for targeting type 1 diabetes mellitus?","Among the genes EMILIN2, SLC25A21, MED20, FSD1, and TMEM14A, which exhibits the highest cell-type specificity in pancreatic acinar cells for targeting type 1 diabetes mellitus? Using a curated list of verified therapeutic targets for type 1 diabetes mellitus, retrieve their cell-type specific gene embeddings from PINNACLE. Then, identify which of these targets overlap with the genes activated in pancreatic acinar cells according to PINNACLE. For the overlapping set, calculate the average embedding, and subsequently compute the cosine similarity between this average and the individual gene embeddings. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in type 1 diabetes mellitus."
"['CDC42BPB', 'IFIT1B', 'MCPH1', 'RASGRP3', 'EFNA3']",type 1 diabetes mellitus,pancreatic acinar cell,RASGRP3,"Among the genes CDC42BPB, IFIT1B, MCPH1, RASGRP3, and EFNA3, which one exhibits the highest level of cell-type-specific expression in pancreatic acinar cells for potential targeting in type 1 diabetes mellitus?","Among the genes CDC42BPB, IFIT1B, MCPH1, RASGRP3, and EFNA3, which one exhibits the highest level of cell-type-specific expression in pancreatic acinar cells for potential targeting in type 1 diabetes mellitus? What are the validated therapeutic targets for type 1 diabetes mellitus, and how do their cell‐type–specific embeddings in PINNACLE compare to the genes activated in pancreatic acinar cells? First, determine the overlapping set between the therapeutic targets and the acinar cell–activated genes. Next, calculate the average embedding for this overlap, and then compute the cosine similarity between each individual target’s embedding and this average reference. If one gene shows a substantially higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence‐based rationale for its biological relevance."
"['FATE1', 'SSPN', 'EPHB1', 'ARFGEF3', 'ASB18']",type 1 diabetes mellitus,pancreatic acinar cell,ARFGEF3,"Among the genes FATE1, SSPN, EPHB1, ARFGEF3, and ASB18, which one shows the highest cell-type specificity in pancreatic acinar cells, making it the most suitable candidate for targeted research in type 1 diabetes mellitus?","Among the genes FATE1, SSPN, EPHB1, ARFGEF3, and ASB18, which one shows the highest cell-type specificity in pancreatic acinar cells, making it the most suitable candidate for targeted research in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the set of pancreatic acinar cell–activated genes in PINNACLE, defining this overlap as the cell-type–specific therapeutic targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping group and calculate the cosine similarity between this average and the embedding for each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['DCDC2', 'MPRIP-AS1', 'MT-ND4L', 'PITPNC1', 'PLEKHF1']",type 1 diabetes mellitus,pancreatic acinar cell,MT-ND4L,"Among the genes DCDC2, MPRIP-AS1, MT-ND4L, PITPNC1, and PLEKHF1, which one demonstrates the highest cell-type specificity in pancreatic acinar cells for targeted interventions in type 1 diabetes research?","Among the genes DCDC2, MPRIP-AS1, MT-ND4L, PITPNC1, and PLEKHF1, which one demonstrates the highest cell-type specificity in pancreatic acinar cells for targeted interventions in type 1 diabetes research? Identify all verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic acinar cell-activated genes in PINNACLE. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. Identify if one gene shows a markedly higher similarity and, if so, nominate it as the top candidate while providing a concise, evidence-based rationale for its biological relevance."
"['ACRBP', 'SAYSD1', 'PAXBP1', 'LINC01922', 'POLR2B']",type 1 diabetes mellitus,pancreatic acinar cell,POLR2B,"Among the genes ACRBP, SAYSD1, PAXBP1, LINC01922, and POLR2B, which one exhibits the highest specificity in pancreatic acinar cells as the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes ACRBP, SAYSD1, PAXBP1, LINC01922, and POLR2B, which one exhibits the highest specificity in pancreatic acinar cells as the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with pancreatic acinar cell-activated genes in PINNACLE. Using the overlapping set as the cell-type–specific targets for type 1 diabetes mellitus, compute their average embedding as a reference and calculate the cosine similarity for each target relative to this reference. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['NXT1', 'NECAB3', 'ADRM1', 'DUXB', 'ARSG']",type 1 diabetes mellitus,pancreatic acinar cell,ARSG,"Which gene among NXT1, NECAB3, ADRM1, DUXB, and ARSG exhibits the highest specificity in pancreatic acinar cells, making it the most appropriate candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among NXT1, NECAB3, ADRM1, DUXB, and ARSG exhibits the highest specificity in pancreatic acinar cells, making it the most appropriate candidate for targeted interventions in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic acinar cell-activated genes in PINNACLE to define the cell-type–specific therapeutic set. Calculate the average embedding of this set and compute the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['IGLC2', 'GSTT2B', 'ZFAND1', 'PRDM5', 'PLGRKT']",type 1 diabetes mellitus,pancreatic acinar cell,PLGRKT,"Which gene among IGLC2, GSTT2B, ZFAND1, PRDM5, and PLGRKT exhibits the highest specificity for pancreatic acinar cells, making it the most appropriate candidate target for type 1 diabetes mellitus?","Which gene among IGLC2, GSTT2B, ZFAND1, PRDM5, and PLGRKT exhibits the highest specificity for pancreatic acinar cells, making it the most appropriate candidate target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell‐type–specific embeddings from PINNACLE. Next, determine which of the genes activated in pancreatic acinar cells (as defined by PINNACLE) overlap with these targets. For this overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF652', 'EPHX1', 'NARF', 'KCNQ4', 'NR1D2']",type 1 diabetes mellitus,pp cell,ZNF652,"Among the genes ZNF652, EPHX1, NARF, KCNQ4, and NR1D2, which one exhibits the highest cell‐type specificity in pancreatic progenitor cells for targeting type 1 diabetes mellitus?","Among the genes ZNF652, EPHX1, NARF, KCNQ4, and NR1D2, which one exhibits the highest cell‐type specificity in pancreatic progenitor cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the set of pp cell-activated genes, and compute the average embedding of the overlapping genes. Then, calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CCDC200', 'HIF1A-AS1', 'TAS2R3', 'NDUFV3', 'NCAPH2']",type 1 diabetes mellitus,pp cell,NDUFV3,"Among the following genes—CCDC200, HIF1A-AS1, TAS2R3, NDUFV3, and NCAPH2—which demonstrates the highest cell-type specificity in pancreatic progenitor cells for targeting type 1 diabetes mellitus?","Among the following genes—CCDC200, HIF1A-AS1, TAS2R3, NDUFV3, and NCAPH2—which demonstrates the highest cell-type specificity in pancreatic progenitor cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the pp cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LINC02848', 'FARP1', 'PDLIM4', 'CD300A', 'PLA2G12A']",type 1 diabetes mellitus,pp cell,PDLIM4,"Among the genes LINC02848, FARP1, PDLIM4, CD300A, and PLA2G12A, which one exhibits the highest cell-type specificity in PP cells relevant for targeting type 1 diabetes mellitus?","Among the genes LINC02848, FARP1, PDLIM4, CD300A, and PLA2G12A, which one exhibits the highest cell-type specificity in PP cells relevant for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus by retrieving their cell-type–specific embeddings from PINNACLE. Next, determine which of the pre-identified cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific disease targets. Compute the average embedding of this overlapping set as a reference profile, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TPGS1', 'C15orf62', 'MYADML2', 'LINC01885', 'PIGN']",type 1 diabetes mellitus,pp cell,TPGS1,"Among TPGS1, C15orf62, MYADML2, LINC01885, and PIGN, which gene exhibits the highest cell-type specificity in pp cells for potential targeting in type 1 diabetes mellitus?","Among TPGS1, C15orf62, MYADML2, LINC01885, and PIGN, which gene exhibits the highest cell-type specificity in pp cells for potential targeting in type 1 diabetes mellitus? Identify and validate therapeutic targets for type 1 diabetes mellitus by extracting their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and the pp cell-activated genes in PINNACLE to define a set of cell-type–specific targets for type 1 diabetes. Calculate the average embedding of this set and compute the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['PCDH18', 'SLC22A10', 'ZNF860', 'RBPJ', 'LINC01970']",type 1 diabetes mellitus,pp cell,RBPJ,"Which gene among PCDH18, SLC22A10, ZNF860, RBPJ, and LINC01970 exhibits the highest cell-type specificity in pp cells relevant to type 1 diabetes mellitus?","Which gene among PCDH18, SLC22A10, ZNF860, RBPJ, and LINC01970 exhibits the highest cell-type specificity in pp cells relevant to type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlapping genes between these targets and the pp cell-activated genes in PINNACLE, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this reference embedding and each individual target. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CASD1', 'SLC45A1', 'KIAA1549', 'ALDH2', 'FAM83E']",type 1 diabetes mellitus,pp cell,ALDH2,"Which gene—CASD1, SLC45A1, KIAA1549, ALDH2, or FAM83E—exhibits the highest cell-type specificity in pp cells for potential therapeutic targeting in type 1 diabetes mellitus?","Which gene—CASD1, SLC45A1, KIAA1549, ALDH2, or FAM83E—exhibits the highest cell-type specificity in pp cells for potential therapeutic targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, compare these with the pp cell-activated genes in PINNACLE to determine the overlapping set representing cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual gene embedding. Finally, nominate the gene with a markedly higher similarity as the top candidate, and provide a concise, evidence-based explanation for its biological relevance."
"['TKFC', 'MRPL16', 'C8orf34-AS1', 'KCNJ9', 'PHF1']",type 1 diabetes mellitus,pp cell,PHF1,"Among TKFC, MRPL16, C8orf34-AS1, KCNJ9, and PHF1, which gene exhibits the highest specificity of expression in pp cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Among TKFC, MRPL16, C8orf34-AS1, KCNJ9, and PHF1, which gene exhibits the highest specificity of expression in pp cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Determine the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, identify which of the pp cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this set as a reference and compute the cosine similarity between the reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BANF2', 'SLC22A1', 'QRICH1', 'NR3C1', 'SPRYD4']",type 1 diabetes mellitus,pp cell,NR3C1,"Which gene among BANF2, SLC22A1, QRICH1, NR3C1, and SPRYD4 exhibits the highest cell-type specificity in pp cells in the context of type 1 diabetes mellitus research?","Which gene among BANF2, SLC22A1, QRICH1, NR3C1, and SPRYD4 exhibits the highest cell-type specificity in pp cells in the context of type 1 diabetes mellitus research? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pp cell-activated genes from PINNACLE overlap with these targets, forming a set of disease-relevant genes. Compute the average embedding of these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KNDC1', 'TRAPPC14', 'ZNF682', 'SMTNL2', 'CACNA1D']",type 1 diabetes mellitus,pp cell,CACNA1D,"Among the genes KNDC1, TRAPPC14, ZNF682, SMTNL2, and CACNA1D, which one exhibits the highest degree of cell-type-specific expression in pp cells to serve as the most suitable candidate for targeting type 1 diabetes mellitus?","Among the genes KNDC1, TRAPPC14, ZNF682, SMTNL2, and CACNA1D, which one exhibits the highest degree of cell-type-specific expression in pp cells to serve as the most suitable candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the pp cell-activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EDEM2', 'BACE1-AS', 'PKD1L3', 'EWSAT1', 'MT-ND3']",type 1 diabetes mellitus,pp cell,MT-ND3,"Among the genes EDEM2, BACE1-AS, PKD1L3, EWSAT1, and MT-ND3, which one exhibits the highest specificity for pancreatic polypeptide cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Among the genes EDEM2, BACE1-AS, PKD1L3, EWSAT1, and MT-ND3, which one exhibits the highest specificity for pancreatic polypeptide cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the pp cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of this overlapping set, then compute the cosine similarity between this reference vector and each target's individual embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RAB14', 'TTN-AS1', 'PRKX', 'KAZALD1', 'LINC01262']",type 1 diabetes mellitus,pp cell,RAB14,"Which gene among RAB14, TTN-AS1, PRKX, KAZALD1, and LINC01262 exhibits the highest cell-type specificity in pp cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among RAB14, TTN-AS1, PRKX, KAZALD1, and LINC01262 exhibits the highest cell-type specificity in pp cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the pp cell-activated genes in PINNACLE overlap with these targets to form the cell-type–specific target set for type 1 diabetes. Compute the average embedding of this set and use cosine similarity to compare each target’s embedding with the average. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAPRE3', 'RPA2', 'KRT78', 'CCDC96', 'PTEN']",type 1 diabetes mellitus,pp cell,PTEN,"Which gene, selected from MAPRE3, RPA2, KRT78, CCDC96, and PTEN, demonstrates the highest cell-type specificity in pancreatic polypeptide cells for targeted intervention in type 1 diabetes mellitus?","Which gene, selected from MAPRE3, RPA2, KRT78, CCDC96, and PTEN, demonstrates the highest cell-type specificity in pancreatic polypeptide cells for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, identify which pp cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set, then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARPP19', 'ACIN1', 'OR6J1', 'IGFN1', 'RBM17']",type 1 diabetes mellitus,pp cell,RBM17,"Among the genes ARPP19, ACIN1, OR6J1, IGFN1, and RBM17, which one exhibits the highest cell-type specificity in pp cells and would therefore be the most promising candidate for targeting in type 1 diabetes mellitus?","Among the genes ARPP19, ACIN1, OR6J1, IGFN1, and RBM17, which one exhibits the highest cell-type specificity in pp cells and would therefore be the most promising candidate for targeting in type 1 diabetes mellitus? Using validated therapeutic targets for type 1 diabetes mellitus, extract their cell-type–specific embeddings from the PINNACLE database. Identify the subset of these targets that overlap with the pp cell–activated genes in PINNACLE, and compute the average embedding for this overlapping set as a reference. Then, calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC02679', 'CEBPA-DT', 'MT-ND4', 'PITPNM2', 'FBXO11']",type 1 diabetes mellitus,pp cell,MT-ND4,"Which gene—LINC02679, CEBPA-DT, MT-ND4, PITPNM2, or FBXO11—displays the highest cell-type specificity in pp cells for potential targeting in type 1 diabetes mellitus?","Which gene—LINC02679, CEBPA-DT, MT-ND4, PITPNM2, or FBXO11—displays the highest cell-type specificity in pp cells for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DNAAF2', 'ARHGEF6', 'KIFC2', 'CHAF1A', 'ATXN7L3B']",type 1 diabetes mellitus,pp cell,ATXN7L3B,"Which gene among DNAAF2, ARHGEF6, KIFC2, CHAF1A, and ATXN7L3B exhibits the highest cell-type specificity in PP cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among DNAAF2, ARHGEF6, KIFC2, CHAF1A, and ATXN7L3B exhibits the highest cell-type specificity in PP cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the PP cell-activated genes in PINNACLE to define the set of cell-type–specific targets. Then, compute the average embedding of these genes and calculate the cosine similarity between this reference and each individual target. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SUCO', 'TTPAL', 'ZNF718', 'NOVA1', 'SNAI3']",type 1 diabetes mellitus,pp cell,SUCO,"Which gene, among SUCO, TTPAL, ZNF718, NOVA1, and SNAI3, shows the most specific expression in pp cells as a candidate target for type 1 diabetes mellitus?","Which gene, among SUCO, TTPAL, ZNF718, NOVA1, and SNAI3, shows the most specific expression in pp cells as a candidate target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell type–specific embeddings from PINNACLE. Next, determine which of the pp cell-activated genes from PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for the disease. Calculate the average embedding for the overlapping set as a reference, and then compute the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation of its biological relevance."
"['ARL14EP', 'EVI5L', 'PPIA', 'B4GALT6', 'YPEL2']",type 1 diabetes mellitus,pp cell,PPIA,"Among the genes ARL14EP, EVI5L, PPIA, B4GALT6, and YPEL2, which one demonstrates the highest cell-type specificity in PP cells relevant to targeting type 1 diabetes mellitus?","Among the genes ARL14EP, EVI5L, PPIA, B4GALT6, and YPEL2, which one demonstrates the highest cell-type specificity in PP cells relevant to targeting type 1 diabetes mellitus? Identify established therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and cell-activated genes in PINNACLE. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LNCARSR', 'KLF3', 'PRANCR', 'FBXO36', 'MC5R']",type 1 diabetes mellitus,pp cell,KLF3,"Which gene among LNCARSR, KLF3, PRANCR, FBXO36, and MC5R exhibits the greatest cell-type specificity in pancreatic polypeptide (PP) cells, thereby emerging as the best candidate for targeting type 1 diabetes mellitus?","Which gene among LNCARSR, KLF3, PRANCR, FBXO36, and MC5R exhibits the greatest cell-type specificity in pancreatic polypeptide (PP) cells, thereby emerging as the best candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of the pp cell-activated genes in PINNACLE overlap with these targets, creating a set of cell-type-specific targets for type 1 diabetes. Compute the average embedding of this set, and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TPH2', 'ERCC6', 'TTC7A', 'SRL', 'PPP1R14B']",type 1 diabetes mellitus,pp cell,PPP1R14B,"Among the genes TPH2, ERCC6, TTC7A, SRL, and PPP1R14B, which one exhibits the highest cell-type specificity in pp cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes TPH2, ERCC6, TTC7A, SRL, and PPP1R14B, which one exhibits the highest cell-type specificity in pp cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and pp cell-activated genes in PINNACLE to define cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. Finally, if one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['QPCT', 'TMEM213', 'BRAF', 'KLK15', 'MED14']",type 1 diabetes mellitus,pp cell,BRAF,"Among the candidate genes QPCT, TMEM213, BRAF, KLK15, and MED14, which one exhibits the highest cell-type specificity in pp cells relevant to type 1 diabetes mellitus?","Among the candidate genes QPCT, TMEM213, BRAF, KLK15, and MED14, which one exhibits the highest cell-type specificity in pp cells relevant to type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the PP cell-activated genes in PINNACLE to define the cell-type-specific targets for type 1 diabetes. Calculate the average embedding of the overlapping targets and compute the cosine similarity between this average and each individual target embedding. Finally, if one gene displays a substantially higher similarity score than the others, nominate it as the top candidate, providing a concise, evidence-based justification for its biological significance."
"['MCPH1', 'MRPL18', 'DLEC1', 'STRN4', 'PRC1']",type 1 diabetes mellitus,type b pancreatic cell,STRN4,"Which gene—MCPH1, MRPL18, DLEC1, STRN4, or PRC1—demonstrates the highest specificity in pancreatic beta cells, making it the most suitable target for type 1 diabetes mellitus interventions?","Which gene—MCPH1, MRPL18, DLEC1, STRN4, or PRC1—demonstrates the highest specificity in pancreatic beta cells, making it the most suitable target for type 1 diabetes mellitus interventions? Identify validated therapeutic targets for type 1 diabetes mellitus from PINNACLE. Retrieve their cell-type–specific embeddings and identify the overlap with genes activated in type b pancreatic cells. Next, compute the average embedding vector of these overlapping targets and calculate the cosine similarity between this reference and each target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPAG6', 'FARP2', 'DANT2', 'ABCC5-AS1', 'H2BC13']",type 1 diabetes mellitus,type b pancreatic cell,FARP2,"Among the candidate genes SPAG6, FARP2, DANT2, ABCC5-AS1, and H2BC13, which one exhibits the highest specificity for pancreatic beta cells in the context of type 1 diabetes mellitus research?","Among the candidate genes SPAG6, FARP2, DANT2, ABCC5-AS1, and H2BC13, which one exhibits the highest specificity for pancreatic beta cells in the context of type 1 diabetes mellitus research? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings using the PINNACLE database. Then, determine which type B pancreatic cell-activated genes overlap with these targets to define cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping gene set and calculate the cosine similarity between this average embedding and each individual target embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FMO4', 'SEC16A', 'LAMB4', 'PRUNE2', 'SLC25A37']",type 1 diabetes mellitus,type b pancreatic cell,SLC25A37,"Among the genes FMO4, SEC16A, LAMB4, PRUNE2, and SLC25A37, which exhibits the highest specificity for expression in type B pancreatic cells and represents the best candidate for targeting type 1 diabetes mellitus?","Among the genes FMO4, SEC16A, LAMB4, PRUNE2, and SLC25A37, which exhibits the highest specificity for expression in type B pancreatic cells and represents the best candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with genes activated in type b pancreatic cells, defining these as the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference vector and calculate the cosine similarity between this reference and each individual target embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide an evidence-based rationale for its biological relevance."
"['CCNT2-AS1', 'PERP', 'CLCN7', 'NUCKS1', 'ABCG5']",type 1 diabetes mellitus,type b pancreatic cell,PERP,"Which gene among CCNT2-AS1, PERP, CLCN7, NUCKS1, and ABCG5 shows the highest specificity in type B pancreatic cell expression for potential targeting in type 1 diabetes mellitus?","Which gene among CCNT2-AS1, PERP, CLCN7, NUCKS1, and ABCG5 shows the highest specificity in type B pancreatic cell expression for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which genes activated in type b pancreatic cells overlap with these targets, considering this subset as the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this subset and then compute the cosine similarity between this average and the embedding of each target gene. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LMX1B', 'ZNF652', 'SLC38A10', 'LINC02651', 'RPS16']",type 1 diabetes mellitus,type b pancreatic cell,ZNF652,"Among the genes LMX1B, ZNF652, SLC38A10, LINC02651, and RPS16, which one exhibits the greatest specificity in pancreatic β-cells, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus?","Among the genes LMX1B, ZNF652, SLC38A10, LINC02651, and RPS16, which one exhibits the greatest specificity in pancreatic β-cells, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which genes activated in type b pancreatic cells (as identified in PINNACLE) overlap with these therapeutic targets. Compute the average embedding of this overlapping gene set and then calculate the cosine similarity between this average and the embedding of each individual gene. Finally, if one gene exhibits notably higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C8orf34-AS1', 'DFFB', 'BSG', 'NUTM2A', 'NDUFA2']",type 1 diabetes mellitus,type b pancreatic cell,NDUFA2,"In type b pancreatic cells, which gene—C8orf34-AS1, DFFB, BSG, NUTM2A, or NDUFA2—exhibits the highest cell-type specificity for targeting type 1 diabetes mellitus?","In type b pancreatic cells, which gene—C8orf34-AS1, DFFB, BSG, NUTM2A, or NDUFA2—exhibits the highest cell-type specificity for targeting type 1 diabetes mellitus? Using PINNACLE, extract the cell-type–specific embeddings for the validated therapeutic targets for type 1 diabetes mellitus. Next, identify which of these targets overlap with the genes activated in type B pancreatic cells, thus defining the cell-type–specific targets for the disease. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['EBP', 'ALOX12B', 'GPANK1', 'NAA80', 'CUTA']",type 1 diabetes mellitus,type b pancreatic cell,CUTA,"Among the genes EBP, ALOX12B, GPANK1, NAA80, and CUTA, which one exhibits the highest cell-type-specific expression in pancreatic beta cells, making it the strongest candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes EBP, ALOX12B, GPANK1, NAA80, and CUTA, which one exhibits the highest cell-type-specific expression in pancreatic beta cells, making it the strongest candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in type b pancreatic cells from PINNACLE to define cell-type–specific targets for the disease. Calculate the average embedding of this overlapping gene set and then compute the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CIRBP', 'FAM78A', 'DMRTA1', 'ARL6IP4', 'FBLN5']",type 1 diabetes mellitus,type b pancreatic cell,DMRTA1,"Which gene among CIRBP, FAM78A, DMRTA1, ARL6IP4, and FBLN5 exhibits the highest specificity to pancreatic beta cells, making it the most promising target for type 1 diabetes mellitus?","Which gene among CIRBP, FAM78A, DMRTA1, ARL6IP4, and FBLN5 exhibits the highest specificity to pancreatic beta cells, making it the most promising target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of the genes activated in type b pancreatic cells within PINNACLE overlap with these therapeutic targets; these overlapping genes represent the cell-type-specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity compared to the others, select it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CTRB1', 'SCN4A', 'DYNC1LI2', 'LINC02805', 'NKTR']",type 1 diabetes mellitus,type b pancreatic cell,CTRB1,"Which gene—CTRB1, SCN4A, DYNC1LI2, LINC02805, or NKTR—exhibits the highest cell-type specificity in β cells of the pancreas in the context of targeting type 1 diabetes mellitus?","Which gene—CTRB1, SCN4A, DYNC1LI2, LINC02805, or NKTR—exhibits the highest cell-type specificity in β cells of the pancreas in the context of targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which type b pancreatic cell–activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LMNTD2', 'BPNT2', 'C1QTNF3', 'CTDSPL', 'CTBP2']",type 1 diabetes mellitus,type b pancreatic cell,CTBP2,"Among the genes LMNTD2, BPNT2, C1QTNF3, CTDSPL, and CTBP2, which one demonstrates the highest cell-type specificity in pancreatic beta cells for targeting type 1 diabetes mellitus?","Among the genes LMNTD2, BPNT2, C1QTNF3, CTDSPL, and CTBP2, which one demonstrates the highest cell-type specificity in pancreatic beta cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the type B pancreatic cell-activated genes in PINNACLE to compile a set of cell-type–specific candidates. Compute the average embedding of these candidates to serve as a reference and calculate the cosine similarity between this reference and each individual candidate. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ZNF570', 'BLTP1', 'PPP1R9B', 'MRPL38', 'SARDH']",type 1 diabetes mellitus,type b pancreatic cell,BLTP1,"Among the genes ZNF570, BLTP1, PPP1R9B, MRPL38, and SARDH, which exhibits the highest specificity in pancreatic beta cells, making it the most promising candidate for therapeutic targeting in type 1 diabetes mellitus?","Among the genes ZNF570, BLTP1, PPP1R9B, MRPL38, and SARDH, which exhibits the highest specificity in pancreatic beta cells, making it the most promising candidate for therapeutic targeting in type 1 diabetes mellitus? Identify and validate therapeutic targets for type 1 diabetes by retrieving their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the type b pancreatic cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding of the overlapping set as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['POMT1', 'VPS29', 'PRUNE2', 'BCR', 'CAVIN1']",type 1 diabetes mellitus,type b pancreatic cell,BCR,"Which gene among POMT1, VPS29, PRUNE2, BCR, and CAVIN1 exhibits the highest specificity in pancreatic beta cells, indicating its potential as the optimal target for therapeutic intervention in type 1 diabetes mellitus?","Which gene among POMT1, VPS29, PRUNE2, BCR, and CAVIN1 exhibits the highest specificity in pancreatic beta cells, indicating its potential as the optimal target for therapeutic intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the genes activated in type b pancreatic cells to define the cell-type–specific targets for T1DM. Compute the average embedding for these overlapping genes as a reference point, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ITLN2', 'DIO2', 'PTPN11', 'METTL5', 'TCEAL8']",type 1 diabetes mellitus,type b pancreatic cell,PTPN11,"Among ITLN2, DIO2, PTPN11, METTL5, and TCEAL8, which gene exhibits the highest specificity for type b pancreatic cells in the context of type 1 diabetes mellitus?","Among ITLN2, DIO2, PTPN11, METTL5, and TCEAL8, which gene exhibits the highest specificity for type b pancreatic cells in the context of type 1 diabetes mellitus? Identify the confirmed therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, compare these targets with the set of type b pancreatic cell-activated genes in PINNACLE to determine overlapping genes that serve as cell-type–specific T1DM targets. Calculate the average embedding for these overlapping genes to create a reference profile, then compute the cosine similarity between this profile and each individual target’s embedding. If one gene shows distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OPN3', 'GTF2A1', 'RGPD6', 'CPA2', 'TSPAN15']",type 1 diabetes mellitus,type b pancreatic cell,GTF2A1,"Which gene among OPN3, GTF2A1, RGPD6, CPA2, and TSPAN15 exhibits the highest cell-type specificity in pancreatic β cells, thereby representing the most promising target for therapeutic intervention in Type 1 diabetes mellitus?","Which gene among OPN3, GTF2A1, RGPD6, CPA2, and TSPAN15 exhibits the highest cell-type specificity in pancreatic β cells, thereby representing the most promising target for therapeutic intervention in Type 1 diabetes mellitus? Using the PINNACLE dataset, identify the verified therapeutic targets for type 1 diabetes and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with genes activated in type b pancreatic cells; this overlapping set serves as the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this set and calculate the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NFAM1', 'ZNF395', 'GSN', 'OBSCN-AS1', 'SULT1A4']",type 1 diabetes mellitus,type b pancreatic cell,GSN,"Among NFAM1, ZNF395, GSN, OBSCN-AS1, and SULT1A4, which gene exhibits the highest expression specificity in pancreatic beta cells as a candidate for targeted intervention in type 1 diabetes mellitus?","Among NFAM1, ZNF395, GSN, OBSCN-AS1, and SULT1A4, which gene exhibits the highest expression specificity in pancreatic beta cells as a candidate for targeted intervention in type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Among the genes activated in type b pancreatic cells in PINNACLE, determine which overlap with these targets, thereby defining the cell-type–specific therapeutic targets for type 1 diabetes mellitus. Next, compute the average embedding of these overlapping targets and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CCBE1', 'RPL39', 'TLX3', 'AP3B1', 'MARCHF5']",type 1 diabetes mellitus,type b pancreatic cell,MARCHF5,"Which gene among CCBE1, RPL39, TLX3, AP3B1, and MARCHF5 exhibits the highest specificity for pancreatic beta-cell expression, thereby representing the most promising candidate target for type 1 diabetes mellitus?","Which gene among CCBE1, RPL39, TLX3, AP3B1, and MARCHF5 exhibits the highest specificity for pancreatic beta-cell expression, thereby representing the most promising candidate target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the intersection between these targets and the type b pancreatic cell-activated genes from PINNACLE to define the cell-type–specific targets. Calculate the average embedding of these overlapping genes and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CLDN22', 'EPC1', 'CAAP1', 'ATXN7L3B', 'DDX23']",type 1 diabetes mellitus,type b pancreatic cell,ATXN7L3B,"Among the genes CLDN22, EPC1, CAAP1, ATXN7L3B, and DDX23, which one exhibits the greatest cell-type specificity in pancreatic beta cells, thereby representing the strongest candidate for targeted interventions in type 1 diabetes mellitus?","Among the genes CLDN22, EPC1, CAAP1, ATXN7L3B, and DDX23, which one exhibits the greatest cell-type specificity in pancreatic beta cells, thereby representing the strongest candidate for targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in type b pancreatic cells according to PINNACLE. For the overlapping set, compute the average embedding as a reference, and then calculate the cosine similarity between this reference and each target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['GTPBP10', 'DIPK2A', 'LINC01098', 'GAGE10', 'CRYBB3']",type 1 diabetes mellitus,type b pancreatic cell,GTPBP10,"Which gene among GTPBP10, DIPK2A, LINC01098, GAGE10, and CRYBB3 exhibits the highest cell-type specific expression in pancreatic beta cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among GTPBP10, DIPK2A, LINC01098, GAGE10, and CRYBB3 exhibits the highest cell-type specific expression in pancreatic beta cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell type–specific embeddings from PINNACLE. Next, determine which of the type B pancreatic cell–activated genes in PINNACLE overlap with these targets; this overlapping set represents the cell type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CCDC149', 'COLEC12', 'DEUP1', 'TPRG1-AS1', 'UCHL3']",type 1 diabetes mellitus,type b pancreatic cell,UCHL3,"Among CCDC149, COLEC12, DEUP1, TPRG1-AS1, and UCHL3, which gene exhibits the highest cell-type specificity in pancreatic beta cells for targeting type 1 diabetes mellitus?","Among CCDC149, COLEC12, DEUP1, TPRG1-AS1, and UCHL3, which gene exhibits the highest cell-type specificity in pancreatic beta cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and type b pancreatic cell-activated genes in PINNACLE to define cell-type–specific targets for type 1 diabetes. Compute the average embedding for this set, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['NANOGP8', 'ALDH2', 'NID2', 'MTX1', 'MGST3']",type 1 diabetes mellitus,type b pancreatic cell,ALDH2,"Among NANOGP8, ALDH2, NID2, MTX1, and MGST3, which gene exhibits the highest specificity for pancreatic β-cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus?","Among NANOGP8, ALDH2, NID2, MTX1, and MGST3, which gene exhibits the highest specificity for pancreatic β-cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which activated genes in type b pancreatic cells overlap with these targets, thereby defining cell-type–specific targets for type 1 diabetes. Compute the mean embedding for these overlapping genes, and calculate the cosine similarity between this reference vector and each individual embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
